Survey of Performance and Management at the Food and Drug Administration (FDA)
U.S. Government Accountability Office
Contents
- Introduction
- Background Information
- FDA's Strategic Goals
- Performance Measurement
- Performance Measurement (Continued)
- Performance Measurement (Continued)
- Agency Climate
- Agency Climate (Continued)
- Agency Climate (Continued)
- Training
- Management Challenges
- Management Challenges - An Example
- Potential Improvements
- Additional Comments and Submit Your Responses to GAO
Introduction
The U.S. Government Accountability Office (GAO), the evaluation arm of Congress, is studying the use
of performance information at FDA as part of a Congressional request. As part of this study, we are
surveying a random sample of mid- and upper-level federal employees at FDA. This survey is
designed to obtain information on your experiences and perceptions with regard to performance management
and related challenges.
This survey is based on similar surveys that we administered in 1996, 1999, 2003, and 2007. Most of the
questions in this survey can be answered by checking boxes or filling in blanks. The survey
should take no more than 20-25 minutes to complete.
We urge you to complete this survey. We cannot develop meaningful information without your frank
and honest answers.
To learn more about completing the survey, printing your responses,
and who to contact if you have questions, _____.
Thank you in advance for your assistance in taking part in our survey.
Background Information
1. What is your current grade level?
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | GS/GM-13 or equivalent | 15.1 | 11.8-18.3 |
| GS/GM-14 or equivalent | 31.7 | 26.8-36.7 | |
| GS/GM-15 or equivalent | 36.8 | 31.9-41.8 | |
| Senior Executive Service or equivalent | 10.6 | 8.1-13.5 | |
| Other - Please specify below, then continue | 5.4 | 3.3-8.5 | |
| Not checked/No Answer | 0.3 | 0.0-1.6 | |
| 2--CDER/CBER/CDRH Managers | GS/GM-13 or equivalent | 2.0 | 0.3-6.3 |
| GS/GM-14 or equivalent | 33.1 | 25.0-41.3 | |
| GS/GM-15 or equivalent | 48.8 | 40.1-57.5 | |
| Senior Executive Service or equivalent | 11.1 | 6.9-16.6 | |
| Other - Please specify below, then continue | 5.0 | 1.9-10.5 | |
| Not checked/No Answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | GS/GM-13 or equivalent | 1.7 | 0.2-6.1 |
| GS/GM-14 or equivalent | 40.1 | 31.1-49.1 | |
| GS/GM-15 or equivalent | 40.1 | 31.1-49.1 | |
| Senior Executive Service or equivalent | 13.2 | 8.1-19.9 | |
| Other - Please specify below, then continue | 5.0 | 1.8-10.9 | |
| Not checked/No Answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | GS/GM-13 or equivalent | 41.2 | 32.4-50.1 |
| GS/GM-14 or equivalent | 32.6 | 24.1-41.0 | |
| GS/GM-15 or equivalent | 14.1 | 8.4-21.7 | |
| Senior Executive Service or equivalent | 3.4 | 1.3-7.2 | |
| Other - Please specify below, then continue | 7.6 | 3.5-14.0 | |
| Not checked/No Answer | 1.1 | 0.1-5.0 |
If you answered "Other" above, please specify your grade level.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
2. In total, for how many years have you been a supervisor and/or
a manager at FDA? (Please specify the total number
of years, rounding up to the nearest year.)
Total number of years as a supervisor and/or
a manager at FDA. (Enter number.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Estimate | 95 Percent Confidence Interval |
||
|---|---|---|---|
| 1--All FDA Managers | Estimated Mean | 8.9 | 8.1-9.7 |
| Estimated Median | 6.5 | 5.6-7.7 | |
| 2--CDER/CBER/CDRH M | Estimated Mean | 9.1 | 7.8-10.3 |
| Estimated Median | 6.9 | 5.4-8.4 | |
| 3--CFSAN Managers | Estimated Mean | 8.2 | 6.9-9.5 |
| Estimated Median | 6.2 | 4.1-7.4 | |
| 4--ORA Managers | Estimated Mean | 9.0 | 7.6-10.3 |
| Estimated Median | 6.1 | 5.1-8.4 | |
If you have never been a supervisor or a
manager at FDA, click on the box below.
1.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
3. In your current role, approximately how many FDA employees and contractors are you
responsible for? (Please answer for your permanent position. Please specify the total number.
If none, enter 0.)
Number of FDA employees . . .
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
Number of contractors . . . . . . .
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
4. Where do you work?
(If you are currently on temporary assignment or on detail,
please answer for your permanent work location.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Inside the Washington, DC metropolitan area | 66.9 | 63.9-69.8 |
| Outside the Washington, DC metropolitan area | 32.3 | 29.3-35.3 | |
| Not checked/No Answer | 0.8 | 0.2-2.2 | |
| 2--CDER/CBER/CDRH Managers | Inside the Washington, DC metropolitan area | 94.8 | 89.1-98.0 |
| Outside the Washington, DC metropolitan area | 5.2 | 2.0-10.9 | |
| Not checked/No Answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Inside the Washington, DC metropolitan area | 93.3 | 87.0-97.2 |
| Outside the Washington, DC metropolitan area | 6.7 | 2.8-13.0 | |
| Not checked/No Answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Inside the Washington, DC metropolitan area | 13.6 | 8.1-21.0 |
| Outside the Washington, DC metropolitan area | 84.2 | 76.5-90.2 | |
| Not checked/No Answer | 2.2 | 0.4-6.7 |
5. For which FDA Center or Office do you work?
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Center for Biologics Evaluation and Research | 9.6 | 9.3-10.0 |
| Center for Device and Radiological Health (C | 10.9 | 10.7-11.0 | |
| Center for Drug Evaluation and Research (CDE | 17.7 | 17.0-18.4 | |
| Center for Food Safety and Applied Nutrition | 9.8 | 9.6-10.0 | |
| Center for Veterinary Medicine (CVM) | 5.3 | 5.2-5.3 | |
| Office of Regulatory Affairs (ORA) | 30.8 | 29.5-32.2 | |
| Office of the Commissioner - National Center | 1.8 | 1.6-2.0 | |
| Office of the Commissioner - Other | 12.1 | 10.9-13.2 | |
| Other - Please specify below, then continue. | 2.1 | 0.8-4.4 | |
| Not checked/No Answer | 0.0 | 0.0-1.0 |
If you answered "Other" above, please specify your FDA Center or Office.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
FDA's Strategic Goals
For the following questions, please interpret "performance measures" in the broadest sense.
6. For those program(s)/operation(s)/project(s) that you are involved with, to what extent, if at all,
do you consider FDA's strategic goals when participating in the following activities?
6a. Setting program priorities
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 36.0 | 30.8-41.2 |
| Great extent | 37.7 | 32.6-42.9 | |
| Moderate extent | 14.8 | 11.5-18.8 | |
| Small extent | 4.4 | 2.5-7.2 | |
| No extent | 2.6 | 1.1-5.2 | |
| No basis to judge/Not applicable | 4.1 | 2.1-7.0 | |
| No answer | 0.3 | 0.0-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 30.6 | 22.3-38.9 |
| Great extent | 43.8 | 35.0-52.7 | |
| Moderate extent | 18.2 | 11.9-26.2 | |
| Small extent | 3.2 | 0.8-8.3 | |
| No extent | 2.1 | 0.3-6.8 | |
| No basis to judge/Not applicable | 2.0 | 0.3-6.3 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 27.1 | 19.1-35.2 |
| Great extent | 41.7 | 32.7-50.8 | |
| Moderate extent | 24.4 | 16.9-33.4 | |
| Small extent | 5.0 | 1.8-10.9 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 0.0 | 0.0-4.8 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 42.9 | 34.1-51.8 |
| Great extent | 28.8 | 20.7-37.0 | |
| Moderate extent | 10.9 | 5.9-17.9 | |
| Small extent | 6.5 | 2.8-12.6 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 6.5 | 2.8-12.6 | |
| No answer | 1.1 | 0.1-5.0 |
6b. Allocating resources
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 29.2 | 24.3-34.1 |
| Great extent | 38.7 | 33.5-43.9 | |
| Moderate extent | 18.7 | 14.7-22.8 | |
| Small extent | 4.0 | 2.1-6.9 | |
| No extent | 3.4 | 1.6-6.1 | |
| No basis to judge/Not applicable | 5.6 | 3.3-8.9 | |
| No answer | 0.3 | 0.0-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 23.3 | 16.0-31.9 |
| Great extent | 47.2 | 38.3-56.1 | |
| Moderate extent | 18.5 | 12.0-26.6 | |
| Small extent | 2.9 | 0.8-7.4 | |
| No extent | 3.1 | 0.8-8.2 | |
| No basis to judge/Not applicable | 5.0 | 2.0-10.3 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 21.1 | 14.0-29.7 |
| Great extent | 41.1 | 32.1-50.2 | |
| Moderate extent | 26.1 | 18.3-35.2 | |
| Small extent | 6.7 | 2.8-13.0 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.6 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 35.3 | 26.8-43.9 |
| Great extent | 31.0 | 22.7-39.3 | |
| Moderate extent | 20.6 | 13.7-29.0 | |
| Small extent | 3.3 | 0.9-8.3 | |
| No extent | 4.3 | 1.5-9.8 | |
| No basis to judge/Not applicable | 4.3 | 1.5-9.8 | |
| No answer | 1.1 | 0.1-5.0 |
6c. Adopting new program approaches or changing work processes
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 29.0 | 24.1-33.8 |
| Great extent | 39.4 | 34.2-44.6 | |
| Moderate extent | 21.8 | 17.5-26.2 | |
| Small extent | 3.7 | 2.1-6.0 | |
| No extent | 2.3 | 0.9-4.7 | |
| No basis to judge/Not applicable | 3.4 | 1.6-6.3 | |
| No answer | 0.5 | 0.1-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 26.0 | 18.5-34.8 |
| Great extent | 43.5 | 34.9-52.2 | |
| Moderate extent | 23.2 | 15.9-31.8 | |
| Small extent | 3.1 | 1.0-7.2 | |
| No extent | 1.2 | 0.1-5.7 | |
| No basis to judge/Not applicable | 3.0 | 0.8-7.7 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 16.1 | 9.9-24.1 |
| Great extent | 36.7 | 27.9-45.6 | |
| Moderate extent | 33.8 | 25.2-42.5 | |
| Small extent | 11.7 | 6.4-19.1 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 0.0 | 0.0-4.8 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 35.3 | 26.8-43.9 |
| Great extent | 34.3 | 25.8-42.8 | |
| Moderate extent | 20.6 | 13.7-29.0 | |
| Small extent | 2.2 | 0.4-6.7 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.3 | |
| No answer | 1.1 | 0.1-5.0 |
6d. Developing or refining program performance measures
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 24.1 | 19.5-28.7 |
| Great extent | 37.4 | 32.2-42.6 | |
| Moderate extent | 22.4 | 17.9-26.9 | |
| Small extent | 7.0 | 4.6-10.1 | |
| No extent | 2.2 | 0.8-4.7 | |
| No basis to judge/Not applicable | 6.6 | 4.1-10.0 | |
| No answer | 0.3 | 0.0-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 21.1 | 14.2-29.5 |
| Great extent | 37.2 | 28.6-45.8 | |
| Moderate extent | 24.2 | 16.8-32.8 | |
| Small extent | 7.2 | 3.3-13.3 | |
| No extent | 2.4 | 0.4-7.4 | |
| No basis to judge/Not applicable | 7.9 | 3.9-13.9 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 13.4 | 7.7-21.1 |
| Great extent | 47.2 | 38.0-56.4 | |
| Moderate extent | 24.4 | 16.9-33.4 | |
| Small extent | 11.7 | 6.4-19.1 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 1.7 | 0.2-6.1 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 24.5 | 17.1-33.2 |
| Great extent | 37.2 | 28.5-45.9 | |
| Moderate extent | 22.0 | 15.0-30.5 | |
| Small extent | 7.6 | 3.5-14.0 | |
| No extent | 1.1 | 0.1-5.0 | |
| No basis to judge/Not applicable | 6.5 | 2.8-12.6 | |
| No answer | 1.1 | 0.1-5.0 |
7. For those program(s)/operation(s)/project(s) that you are involved with, to what extent, if at all, do you consider goals from the following FDA plans or initiatives when making management decisions such as setting priorities or allocating resources?
7a. Food Protection Plan
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 19.0 | 15.6-22.4 |
| Great extent | 13.1 | 10.0-16.7 | |
| Moderate extent | 7.0 | 5.1-9.5 | |
| Small extent | 7.4 | 4.7-10.9 | |
| No extent | 11.4 | 8.1-15.4 | |
| No basis to judge/Not applicable | 39.8 | 35.0-44.6 | |
| No answer | 2.4 | 1.1-4.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 1.0 | 0.1-4.8 |
| Great extent | 0.0 | 0.0-2.9 | |
| Moderate extent | 0.0 | 0.0-2.9 | |
| Small extent | 3.2 | 0.8-8.3 | |
| No extent | 22.3 | 15.1-30.9 | |
| No basis to judge/Not applicable | 67.7 | 59.3-76.0 | |
| No answer | 5.9 | 2.4-11.7 | |
| 3--CFSAN Managers | Very great extent | 42.2 | 33.1-51.2 |
| Great extent | 22.8 | 15.4-31.6 | |
| Moderate extent | 21.7 | 14.5-30.5 | |
| Small extent | 1.7 | 0.2-6.1 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 8.3 | 4.0-15.1 | |
| No answer | 1.7 | 0.2-6.1 | |
| 4--ORA Managers | Very great extent | 31.0 | 22.7-39.3 |
| Great extent | 23.1 | 15.9-31.7 | |
| Moderate extent | 11.2 | 6.2-18.2 | |
| Small extent | 13.0 | 7.5-20.5 | |
| No extent | 4.3 | 1.5-9.8 | |
| No basis to judge/Not applicable | 17.4 | 11.0-25.4 | |
| No answer | 0.0 | 0.0-3.1 |
7b. Critical Path Initiative
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 9.3 | 6.3-13.0 |
| Great extent | 22.0 | 17.6-26.5 | |
| Moderate extent | 20.3 | 16.0-24.6 | |
| Small extent | 16.6 | 12.7-21.0 | |
| No extent | 9.2 | 6.5-12.5 | |
| No basis to judge/Not applicable | 21.9 | 17.5-26.3 | |
| No answer | 0.8 | 0.1-3.0 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 10.2 | 5.4-17.1 |
| Great extent | 30.4 | 22.2-38.6 | |
| Moderate extent | 19.2 | 12.6-27.5 | |
| Small extent | 20.0 | 13.3-28.2 | |
| No extent | 5.1 | 1.9-10.7 | |
| No basis to judge/Not applicable | 15.1 | 9.3-22.8 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 3.3 | 0.9-8.6 |
| Great extent | 11.7 | 6.4-19.1 | |
| Moderate extent | 12.1 | 7.0-19.1 | |
| Small extent | 25.0 | 17.4-34.1 | |
| No extent | 16.7 | 10.3-24.9 | |
| No basis to judge/Not applicable | 29.4 | 21.1-37.8 | |
| No answer | 1.7 | 0.2-6.1 | |
| 4--ORA Managers | Very great extent | 3.6 | 1.1-8.4 |
| Great extent | 19.8 | 13.1-28.1 | |
| Moderate extent | 23.9 | 16.5-32.6 | |
| Small extent | 9.8 | 5.1-16.6 | |
| No extent | 15.5 | 9.5-23.3 | |
| No basis to judge/Not applicable | 27.4 | 19.4-35.5 | |
| No answer | 0.0 | 0.0-3.1 |
7c. ORA Revitalization Plan
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 4.9 | 3.1-7.5 |
| Great extent | 9.6 | 6.9-13.1 | |
| Moderate extent | 13.8 | 10.6-17.5 | |
| Small extent | 10.8 | 7.6-14.7 | |
| No extent | 14.0 | 10.6-18.1 | |
| No basis to judge/Not applicable | 44.4 | 39.6-49.3 | |
| No answer | 2.4 | 1.1-4.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 0.0 | 0.0-2.9 |
| Great extent | 0.3 | 0.1-0.9 | |
| Moderate extent | 4.8 | 1.7-10.3 | |
| Small extent | 7.5 | 3.4-14.0 | |
| No extent | 16.5 | 10.4-24.3 | |
| No basis to judge/Not applicable | 65.1 | 56.7-73.5 | |
| No answer | 5.9 | 2.4-11.7 | |
| 3--CFSAN Managers | Very great extent | 0.0 | 0.0-4.8 |
| Great extent | 5.0 | 1.8-10.9 | |
| Moderate extent | 21.1 | 14.0-29.7 | |
| Small extent | 8.3 | 4.0-15.1 | |
| No extent | 30.1 | 21.6-38.5 | |
| No basis to judge/Not applicable | 33.8 | 25.2-42.5 | |
| No answer | 1.7 | 0.2-6.1 | |
| 4--ORA Managers | Very great extent | 15.5 | 9.5-23.3 |
| Great extent | 20.2 | 13.4-28.4 | |
| Moderate extent | 25.3 | 17.8-34.1 | |
| Small extent | 13.0 | 7.5-20.5 | |
| No extent | 9.8 | 5.1-16.6 | |
| No basis to judge/Not applicable | 16.3 | 10.1-24.2 | |
| No answer | 0.0 | 0.0-3.1 |
7d. Other - Please specify below.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
If you answered "Other" above, please specify other FDA plans or initiatives you consider when making management decisions.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
Performance Measurement
8. Are there performance measures for the program(s)/operation(s)/project(s) that you are involved with?
(Note: For respondents not answering "Yes" to this question, the responses for questions 9, 10, 12,
and 13 are set to "No Answer".)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Yes - (Continue with question 9.) | 73.1 | 68.3-77.9 |
| No | 19.0 | 14.7-23.4 | |
| Do not know | 6.5 | 4.0-9.9 | |
| Not checked | 1.4 | 0.5-3.2 | |
| 2--CDER/CBER/CDRH Managers | Yes - (Continue with question 9.) | 70.0 | 61.8-78.2 |
| No | 21.1 | 14.2-29.4 | |
| Do not know | 7.1 | 3.2-13.2 | |
| Not checked | 1.9 | 0.3-5.8 | |
| 3--CFSAN Managers | Yes - (Continue with question 9.) | 80.6 | 72.2-87.4 |
| No | 15.0 | 9.0-23.0 | |
| Do not know | 4.4 | 1.6-9.4 | |
| Not checked | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Yes - (Continue with question 9.) | 80.2 | 71.9-86.9 |
| No | 13.3 | 7.8-20.7 | |
| Do not know | 4.3 | 1.5-9.8 | |
| Not checked | 2.2 | 0.4-6.7 |
9. To what extent, if at all, do you agree with the following statements as they relate to
performance measures for the program(s)/operation(s)/project(s) that you are involved with?
9a. We have performance measures that tell us how many things we produce or services we provide. (Output measures)
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 26.4 | 21.7-31.1 |
| Great extent | 26.9 | 22.2-31.7 | |
| Moderate extent | 12.5 | 9.3-16.4 | |
| Small extent | 4.2 | 2.4-6.7 | |
| No extent | 1.7 | 0.7-3.5 | |
| No basis to judge/Not applicable | 1.3 | 0.3-3.6 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 23.5 | 16.3-32.1 |
| Great extent | 25.4 | 17.9-34.0 | |
| Moderate extent | 14.8 | 9.0-22.4 | |
| Small extent | 5.4 | 2.0-11.3 | |
| No extent | 0.9 | 0.1-4.4 | |
| No basis to judge/Not applicable | 0.0 | 0.0-2.9 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 28.4 | 20.1-36.7 |
| Great extent | 24.4 | 16.9-33.4 | |
| Moderate extent | 19.4 | 12.6-27.9 | |
| Small extent | 5.0 | 1.8-10.9 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 0.0 | 0.0-4.8 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 31.3 | 23.0-39.6 |
| Great extent | 30.4 | 22.1-38.7 | |
| Moderate extent | 8.7 | 4.3-15.3 | |
| Small extent | 4.3 | 1.5-9.8 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 2.2 | 0.4-6.7 | |
| No answer | 19.8 | 13.1-28.1 |
9b. We have performance measures that tell us if we are operating efficiently. (Efficiency measures)
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 9.5 | 6.6-13.0 |
| Great extent | 25.3 | 20.7-29.8 | |
| Moderate extent | 22.1 | 17.8-26.5 | |
| Small extent | 10.4 | 7.5-14.0 | |
| No extent | 4.9 | 3.0-7.6 | |
| No basis to judge/Not applicable | 0.5 | 0.1-1.7 | |
| No answer | 27.3 | 22.5-32.1 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 6.0 | 2.5-11.7 |
| Great extent | 17.8 | 11.8-25.3 | |
| Moderate extent | 26.6 | 18.7-34.5 | |
| Small extent | 13.5 | 7.9-21.1 | |
| No extent | 6.1 | 2.5-12.0 | |
| No basis to judge/Not applicable | 0.0 | 0.0-2.9 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 13.4 | 7.7-21.1 |
| Great extent | 21.7 | 14.5-30.5 | |
| Moderate extent | 17.7 | 11.3-26.0 | |
| Small extent | 17.7 | 11.3-26.0 | |
| No extent | 8.3 | 4.0-15.1 | |
| No basis to judge/Not applicable | 1.7 | 0.2-6.1 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 8.7 | 4.3-15.3 |
| Great extent | 34.3 | 25.8-42.8 | |
| Moderate extent | 21.7 | 14.7-30.2 | |
| Small extent | 7.9 | 3.8-14.2 | |
| No extent | 5.4 | 2.1-11.2 | |
| No basis to judge/Not applicable | 1.1 | 0.1-5.0 | |
| No answer | 20.9 | 14.0-29.3 |
9c. We have performance measures that tell us whether or not we are satisfying our customers. (Customer service measures)
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 7.1 | 4.5-10.4 |
| Great extent | 20.5 | 16.1-24.8 | |
| Moderate extent | 25.4 | 20.8-30.0 | |
| Small extent | 13.1 | 9.8-17.0 | |
| No extent | 5.0 | 3.2-7.5 | |
| No basis to judge/Not applicable | 2.0 | 0.8-4.0 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 6.4 | 2.7-12.4 |
| Great extent | 15.9 | 10.0-23.5 | |
| Moderate extent | 27.3 | 19.3-35.3 | |
| Small extent | 12.3 | 7.1-19.4 | |
| No extent | 6.1 | 2.6-12.1 | |
| No basis to judge/Not applicable | 2.0 | 0.3-6.3 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 8.3 | 4.0-15.1 |
| Great extent | 18.4 | 11.7-26.8 | |
| Moderate extent | 20.5 | 13.6-28.8 | |
| Small extent | 16.7 | 10.3-24.9 | |
| No extent | 15.0 | 9.0-23.0 | |
| No basis to judge/Not applicable | 1.7 | 0.2-6.1 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 6.5 | 2.8-12.6 |
| Great extent | 23.1 | 15.9-31.7 | |
| Moderate extent | 26.4 | 18.7-35.2 | |
| Small extent | 17.7 | 11.3-25.7 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.3 | |
| No answer | 19.8 | 13.1-28.1 |
9d. We have performance measures that tell us about the quality of the products or services we provide. (Quality measures)
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 9.3 | 6.4-12.9 |
| Great extent | 27.3 | 22.5-32.0 | |
| Moderate extent | 22.3 | 17.9-26.6 | |
| Small extent | 9.5 | 6.8-12.9 | |
| No extent | 4.6 | 2.7-7.2 | |
| No basis to judge/Not applicable | 0.2 | 0.0-0.6 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 9.4 | 4.7-16.2 |
| Great extent | 22.3 | 15.4-30.6 | |
| Moderate extent | 19.3 | 12.9-27.3 | |
| Small extent | 12.8 | 7.4-20.2 | |
| No extent | 6.1 | 2.6-12.1 | |
| No basis to judge/Not applicable | 0.0 | 0.0-2.9 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 8.3 | 4.0-15.1 |
| Great extent | 29.4 | 21.1-37.8 | |
| Moderate extent | 19.4 | 12.6-27.9 | |
| Small extent | 13.4 | 7.7-21.1 | |
| No extent | 8.3 | 4.0-15.1 | |
| No basis to judge/Not applicable | 1.7 | 0.2-6.1 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 10.9 | 5.9-17.9 |
| Great extent | 29.3 | 21.1-37.5 | |
| Moderate extent | 25.9 | 18.4-34.6 | |
| Small extent | 9.8 | 5.1-16.6 | |
| No extent | 4.3 | 1.5-9.8 | |
| No basis to judge/Not applicable | 0.0 | 0.0-3.1 | |
| No answer | 19.8 | 13.1-28.1 |
9e. We have performance measures that would demonstrate to someone outside of our agency whether or not we are achieving our intended results. (Outcome measures)
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 12.5 | 9.1-16.6 |
| Great extent | 31.2 | 26.3-36.1 | |
| Moderate extent | 15.5 | 11.9-19.7 | |
| Small extent | 9.1 | 6.5-12.3 | |
| No extent | 3.5 | 1.9-5.9 | |
| No basis to judge/Not applicable | 1.3 | 0.3-3.7 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 12.3 | 7.0-19.5 |
| Great extent | 27.8 | 19.8-35.8 | |
| Moderate extent | 17.7 | 11.5-25.4 | |
| Small extent | 7.0 | 3.2-13.2 | |
| No extent | 4.2 | 1.4-9.6 | |
| No basis to judge/Not applicable | 1.0 | 0.1-4.8 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 16.7 | 10.3-24.9 |
| Great extent | 30.1 | 21.6-38.5 | |
| Moderate extent | 12.1 | 7.0-19.1 | |
| Small extent | 16.7 | 10.3-24.9 | |
| No extent | 5.0 | 1.8-10.9 | |
| No basis to judge/Not applicable | 0.0 | 0.0-4.8 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 7.6 | 3.5-14.0 |
| Great extent | 38.0 | 29.3-46.7 | |
| Moderate extent | 15.5 | 9.5-23.3 | |
| Small extent | 13.6 | 8.1-21.0 | |
| No extent | 4.3 | 1.5-9.8 | |
| No basis to judge/Not applicable | 1.1 | 0.1-5.0 | |
| No answer | 19.8 | 13.1-28.1 |
9f. We have performance measures that link our product or service costs with the results we achieve. (Cost-benefit measures)
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 4.6 | 2.5-7.5 |
| Great extent | 9.6 | 6.7-13.3 | |
| Moderate extent | 16.1 | 12.4-20.4 | |
| Small extent | 17.2 | 13.4-21.1 | |
| No extent | 12.8 | 9.6-16.5 | |
| No basis to judge/Not applicable | 12.8 | 9.3-16.9 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 3.1 | 0.8-8.2 |
| Great extent | 3.4 | 1.1-8.0 | |
| Moderate extent | 15.6 | 9.8-23.2 | |
| Small extent | 15.7 | 9.8-23.5 | |
| No extent | 16.7 | 10.5-24.6 | |
| No basis to judge/Not applicable | 15.4 | 9.4-23.2 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 3.3 | 0.9-8.6 |
| Great extent | 6.7 | 2.8-13.0 | |
| Moderate extent | 14.4 | 8.6-22.1 | |
| Small extent | 27.8 | 19.5-36.0 | |
| No extent | 18.4 | 11.7-26.8 | |
| No basis to judge/Not applicable | 10.0 | 5.1-17.1 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 2.2 | 0.4-6.7 |
| Great extent | 16.3 | 10.1-24.2 | |
| Moderate extent | 16.6 | 10.4-24.5 | |
| Small extent | 18.8 | 12.2-26.9 | |
| No extent | 13.3 | 7.8-20.7 | |
| No basis to judge/Not applicable | 13.0 | 7.5-20.5 | |
| No answer | 19.8 | 13.1-28.1 |
Performance Measurement (Continued)
10. For those program(s)/operation(s)/project(s) that you are involved with, to what extent, if at all, do you use the information obtained from performance measurement when participating in the following activities?
10a. Developing program strategy
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 10.8 | 7.6-14.7 |
| Great extent | 29.4 | 24.6-34.2 | |
| Moderate extent | 22.8 | 18.4-27.2 | |
| Small extent | 5.1 | 3.1-7.9 | |
| No extent | 1.8 | 0.7-3.7 | |
| No basis to judge/Not applicable | 3.1 | 1.4-5.9 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 6.8 | 3.2-12.7 |
| Great extent | 27.8 | 19.8-35.7 | |
| Moderate extent | 26.2 | 18.6-35.1 | |
| Small extent | 6.9 | 3.2-12.9 | |
| No extent | 1.2 | 0.1-5.7 | |
| No basis to judge/Not applicable | 1.0 | 0.1-4.8 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 6.7 | 2.8-13.0 |
| Great extent | 36.1 | 27.3-45.0 | |
| Moderate extent | 29.4 | 21.1-37.8 | |
| Small extent | 3.3 | 0.9-8.6 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 1.7 | 0.2-6.1 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 13.0 | 7.5-20.5 |
| Great extent | 33.5 | 25.1-41.9 | |
| Moderate extent | 19.5 | 12.8-27.8 | |
| Small extent | 6.5 | 2.8-12.6 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 4.3 | 1.5-9.8 | |
| No answer | 19.8 | 13.1-28.1 |
10b. Setting program priorities
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 15.3 | 11.6-19.6 |
| Great extent | 33.2 | 28.3-38.2 | |
| Moderate extent | 13.8 | 10.4-17.8 | |
| Small extent | 5.8 | 3.5-9.0 | |
| No extent | 2.1 | 0.9-4.3 | |
| No basis to judge/Not applicable | 2.5 | 1.1-5.0 | |
| No answer | 27.3 | 22.5-32.1 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 11.9 | 6.8-19.0 |
| Great extent | 32.8 | 24.4-41.1 | |
| Moderate extent | 14.7 | 8.9-22.4 | |
| Small extent | 7.2 | 3.2-13.5 | |
| No extent | 2.4 | 0.4-7.4 | |
| No basis to judge/Not applicable | 1.0 | 0.1-4.8 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 6.7 | 2.8-13.0 |
| Great extent | 41.1 | 32.1-50.2 | |
| Moderate extent | 26.1 | 18.3-35.2 | |
| Small extent | 3.3 | 0.9-8.6 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 1.7 | 0.2-6.1 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 19.5 | 12.8-27.8 |
| Great extent | 35.7 | 27.1-44.2 | |
| Moderate extent | 9.8 | 5.1-16.6 | |
| Small extent | 6.5 | 2.8-12.6 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 4.3 | 1.5-9.8 | |
| No answer | 20.9 | 14.0-29.3 |
10c. Allocating resources
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 14.0 | 10.6-18.1 |
| Great extent | 33.1 | 28.1-38.1 | |
| Moderate extent | 16.8 | 12.8-20.7 | |
| Small extent | 3.4 | 1.8-5.8 | |
| No extent | 1.8 | 0.7-3.5 | |
| No basis to judge/Not applicable | 3.6 | 1.8-6.4 | |
| No answer | 27.3 | 22.5-32.1 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 12.5 | 7.3-19.5 |
| Great extent | 29.5 | 21.5-37.5 | |
| Moderate extent | 19.7 | 13.0-27.9 | |
| Small extent | 3.1 | 0.8-8.2 | |
| No extent | 1.0 | 0.1-4.8 | |
| No basis to judge/Not applicable | 3.2 | 0.8-8.3 | |
| No answer | 31.0 | 22.7-39.3 | |
| 3--CFSAN Managers | Very great extent | 9.4 | 4.8-16.1 |
| Great extent | 36.7 | 27.9-45.6 | |
| Moderate extent | 22.8 | 15.4-31.6 | |
| Small extent | 5.0 | 1.8-10.9 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.6 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 16.3 | 10.1-24.2 |
| Great extent | 38.9 | 30.2-47.6 | |
| Moderate extent | 13.0 | 7.5-20.5 | |
| Small extent | 5.4 | 2.1-11.2 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.3 | |
| No answer | 19.8 | 13.1-28.1 |
10d. Identifying program problems to be addressed
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 14.3 | 10.7-18.7 |
| Great extent | 32.3 | 27.4-37.2 | |
| Moderate extent | 19.2 | 14.9-23.4 | |
| Small extent | 3.4 | 1.9-5.7 | |
| No extent | 1.5 | 0.5-3.3 | |
| No basis to judge/Not applicable | 1.4 | 0.4-3.3 | |
| No answer | 27.9 | 23.1-32.8 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 11.1 | 6.1-18.1 |
| Great extent | 35.2 | 26.7-43.7 | |
| Moderate extent | 17.4 | 11.1-25.4 | |
| Small extent | 2.9 | 0.8-7.6 | |
| No extent | 1.2 | 0.1-5.7 | |
| No basis to judge/Not applicable | 2.2 | 0.3-7.0 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 11.7 | 6.4-19.1 |
| Great extent | 36.1 | 27.3-45.0 | |
| Moderate extent | 21.7 | 14.5-30.5 | |
| Small extent | 4.4 | 1.6-9.4 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 1.7 | 0.2-6.1 | |
| No answer | 21.1 | 14.0-29.7 | |
| 4--ORA Managers | Very great extent | 14.1 | 8.4-21.7 |
| Great extent | 36.1 | 27.5-44.8 | |
| Moderate extent | 20.2 | 13.4-28.4 | |
| Small extent | 5.4 | 2.1-11.2 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 1.1 | 0.1-5.0 | |
| No answer | 20.9 | 14.0-29.3 |
10e. Taking corrective action to solve program problems
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 14.1 | 10.4-18.4 |
| Great extent | 33.6 | 28.7-38.6 | |
| Moderate extent | 16.6 | 12.8-20.5 | |
| Small extent | 5.8 | 3.5-8.8 | |
| No extent | 1.2 | 0.4-3.1 | |
| No basis to judge/Not applicable | 1.4 | 0.4-3.3 | |
| No answer | 27.3 | 22.5-32.1 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 12.1 | 6.9-19.2 |
| Great extent | 33.5 | 25.2-41.9 | |
| Moderate extent | 16.7 | 10.5-24.5 | |
| Small extent | 3.1 | 0.8-8.2 | |
| No extent | 2.4 | 0.4-7.4 | |
| No basis to judge/Not applicable | 2.2 | 0.3-7.0 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 10.0 | 5.1-17.1 |
| Great extent | 29.4 | 21.1-37.8 | |
| Moderate extent | 31.1 | 22.6-39.6 | |
| Small extent | 5.0 | 1.8-10.9 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 1.7 | 0.2-6.1 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 14.1 | 8.4-21.7 |
| Great extent | 38.3 | 29.6-47.0 | |
| Moderate extent | 14.7 | 9.0-22.3 | |
| Small extent | 10.9 | 5.9-17.9 | |
| No extent | 0.0 | 0.0-3.1 | |
| No basis to judge/Not applicable | 1.1 | 0.1-5.0 | |
| No answer | 20.9 | 14.0-29.3 |
10f. Adopting new program approaches or changing work processes
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 9.7 | 6.8-13.4 |
| Great extent | 35.5 | 30.5-40.6 | |
| Moderate extent | 19.6 | 15.3-23.8 | |
| Small extent | 5.7 | 3.6-8.7 | |
| No extent | 1.5 | 0.5-3.3 | |
| No basis to judge/Not applicable | 1.0 | 0.2-2.8 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 4.3 | 1.6-9.0 |
| Great extent | 39.1 | 30.4-47.8 | |
| Moderate extent | 17.1 | 10.8-25.0 | |
| Small extent | 6.1 | 2.6-12.1 | |
| No extent | 1.2 | 0.1-5.7 | |
| No basis to judge/Not applicable | 2.2 | 0.3-7.0 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 8.3 | 4.0-15.1 |
| Great extent | 41.1 | 32.1-50.2 | |
| Moderate extent | 23.4 | 15.9-32.3 | |
| Small extent | 2.7 | 0.8-6.7 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 1.7 | 0.2-6.1 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 11.9 | 6.7-19.2 |
| Great extent | 36.1 | 27.5-44.8 | |
| Moderate extent | 20.2 | 13.4-28.4 | |
| Small extent | 9.8 | 5.1-16.6 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 0.0 | 0.0-3.1 | |
| No answer | 19.8 | 13.1-28.1 |
10g. Coordinating program efforts with other internal or external organizations
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 9.3 | 6.4-13.1 |
| Great extent | 29.2 | 24.4-33.9 | |
| Moderate extent | 20.2 | 16.0-24.5 | |
| Small extent | 9.9 | 7.1-13.5 | |
| No extent | 1.8 | 0.6-4.1 | |
| No basis to judge/Not applicable | 2.6 | 1.3-4.8 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 6.3 | 2.8-12.1 |
| Great extent | 27.5 | 19.6-35.4 | |
| Moderate extent | 23.7 | 16.5-32.3 | |
| Small extent | 9.4 | 4.7-16.2 | |
| No extent | 0.0 | 0.0-2.9 | |
| No basis to judge/Not applicable | 3.1 | 0.8-8.2 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 5.0 | 1.8-10.9 |
| Great extent | 25.0 | 17.4-34.1 | |
| Moderate extent | 24.4 | 16.9-33.4 | |
| Small extent | 17.7 | 11.3-26.0 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 6.7 | 2.8-13.0 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 10.9 | 5.9-17.9 |
| Great extent | 37.5 | 28.8-46.2 | |
| Moderate extent | 16.6 | 10.4-24.5 | |
| Small extent | 10.9 | 5.9-17.9 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 1.1 | 0.1-5.0 | |
| No answer | 19.8 | 13.1-28.1 |
10h. Refining program performance measures
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 9.1 | 6.3-12.7 |
| Great extent | 24.9 | 20.3-29.6 | |
| Moderate extent | 23.5 | 19.0-27.9 | |
| Small extent | 7.5 | 5.0-10.7 | |
| No extent | 3.5 | 1.9-5.7 | |
| No basis to judge/Not applicable | 4.6 | 2.6-7.4 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 7.7 | 3.7-13.7 |
| Great extent | 26.2 | 18.6-35.1 | |
| Moderate extent | 23.5 | 16.6-31.7 | |
| Small extent | 8.6 | 4.2-15.4 | |
| No extent | 0.9 | 0.1-4.4 | |
| No basis to judge/Not applicable | 2.9 | 0.8-7.6 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 6.7 | 2.8-13.0 |
| Great extent | 30.1 | 21.6-38.5 | |
| Moderate extent | 32.2 | 23.6-40.7 | |
| Small extent | 5.0 | 1.8-10.9 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.6 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 7.6 | 3.5-14.0 |
| Great extent | 25.3 | 17.8-34.1 | |
| Moderate extent | 19.5 | 12.8-27.8 | |
| Small extent | 11.2 | 6.2-18.2 | |
| No extent | 8.7 | 4.3-15.3 | |
| No basis to judge/Not applicable | 7.9 | 3.8-14.2 | |
| No answer | 19.8 | 13.1-28.1 |
10i. Setting new or revising existing performance goals
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 10.9 | 7.8-14.8 |
| Great extent | 26.6 | 22.0-31.3 | |
| Moderate extent | 22.8 | 18.4-27.3 | |
| Small extent | 4.8 | 2.8-7.6 | |
| No extent | 2.7 | 1.4-4.8 | |
| No basis to judge/Not applicable | 5.1 | 2.9-8.2 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 8.1 | 4.0-14.4 |
| Great extent | 27.1 | 19.1-35.0 | |
| Moderate extent | 26.3 | 18.8-35.0 | |
| Small extent | 5.5 | 2.1-11.5 | |
| No extent | 0.0 | 0.0-2.9 | |
| No basis to judge/Not applicable | 2.9 | 0.8-7.6 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 10.0 | 5.1-17.1 |
| Great extent | 34.4 | 25.7-43.2 | |
| Moderate extent | 27.8 | 19.5-36.0 | |
| Small extent | 1.7 | 0.2-6.1 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.6 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 9.8 | 5.1-16.6 |
| Great extent | 28.5 | 20.4-36.6 | |
| Moderate extent | 19.1 | 12.5-27.2 | |
| Small extent | 7.6 | 3.5-14.0 | |
| No extent | 7.6 | 3.5-14.0 | |
| No basis to judge/Not applicable | 7.6 | 3.5-14.0 | |
| No answer | 19.8 | 13.1-28.1 |
10j. Setting individual job expectations for the government employees I manage or supervise
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 15.7 | 12.1-19.9 |
| Great extent | 39.7 | 34.5-44.8 | |
| Moderate extent | 10.8 | 7.7-14.5 | |
| Small extent | 3.9 | 2.2-6.5 | |
| No extent | 0.8 | 0.2-2.3 | |
| No basis to judge/Not applicable | 2.0 | 0.8-4.2 | |
| No answer | 27.1 | 22.3-31.9 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 12.7 | 7.3-20.0 |
| Great extent | 43.3 | 34.7-52.0 | |
| Moderate extent | 8.3 | 4.2-14.3 | |
| Small extent | 2.5 | 0.5-7.1 | |
| No extent | 1.2 | 0.1-5.7 | |
| No basis to judge/Not applicable | 2.0 | 0.3-6.3 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 16.1 | 9.9-24.1 |
| Great extent | 36.7 | 27.9-45.6 | |
| Moderate extent | 10.0 | 5.1-17.1 | |
| Small extent | 7.7 | 3.7-14.0 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 5.0 | 1.8-10.9 | |
| No answer | 21.1 | 14.0-29.7 | |
| 4--ORA Managers | Very great extent | 20.6 | 13.7-29.0 |
| Great extent | 41.6 | 32.7-50.4 | |
| Moderate extent | 13.0 | 7.5-20.5 | |
| Small extent | 4.6 | 1.7-10.0 | |
| No extent | 0.0 | 0.0-3.1 | |
| No basis to judge/Not applicable | 0.3 | 0.1-0.7 | |
| No answer | 19.8 | 13.1-28.1 |
10k. Rewarding government employees I manage or supervise
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 16.1 | 12.4-20.3 |
| Great extent | 37.4 | 32.4-42.5 | |
| Moderate extent | 11.3 | 8.2-15.1 | |
| Small extent | 3.1 | 1.6-5.5 | |
| No extent | 1.9 | 0.7-4.3 | |
| No basis to judge/Not applicable | 3.2 | 1.5-5.8 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 14.8 | 9.0-22.4 |
| Great extent | 37.0 | 28.6-45.4 | |
| Moderate extent | 11.6 | 6.5-18.7 | |
| Small extent | 1.5 | 0.2-5.5 | |
| No extent | 2.2 | 0.3-7.0 | |
| No basis to judge/Not applicable | 2.9 | 0.8-7.6 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 12.7 | 7.3-20.2 |
| Great extent | 30.1 | 21.6-38.5 | |
| Moderate extent | 17.7 | 11.3-26.0 | |
| Small extent | 6.7 | 2.8-13.0 | |
| No extent | 5.0 | 1.8-10.9 | |
| No basis to judge/Not applicable | 8.3 | 4.0-15.1 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 22.8 | 15.6-31.4 |
| Great extent | 44.0 | 35.1-52.9 | |
| Moderate extent | 10.1 | 5.4-16.9 | |
| Small extent | 3.3 | 0.9-8.3 | |
| No extent | 0.0 | 0.0-3.1 | |
| No basis to judge/Not applicable | 0.0 | 0.0-3.1 | |
| No answer | 19.8 | 13.1-28.1 |
10l. Developing and managing contracts
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 5.6 | 3.5-8.5 |
| Great extent | 13.0 | 9.8-16.8 | |
| Moderate extent | 12.4 | 9.2-16.2 | |
| Small extent | 6.3 | 3.9-9.5 | |
| No extent | 7.0 | 4.5-10.4 | |
| No basis to judge/Not applicable | 28.8 | 24.0-33.6 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 3.1 | 0.8-8.0 |
| Great extent | 14.3 | 8.7-21.8 | |
| Moderate extent | 12.9 | 7.6-20.1 | |
| Small extent | 6.7 | 2.8-13.0 | |
| No extent | 6.3 | 2.6-12.5 | |
| No basis to judge/Not applicable | 26.6 | 19.0-34.3 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 8.3 | 4.0-15.1 |
| Great extent | 10.0 | 5.1-17.1 | |
| Moderate extent | 22.8 | 15.4-31.6 | |
| Small extent | 6.1 | 2.6-11.8 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 31.7 | 23.2-40.3 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 6.5 | 2.8-12.6 |
| Great extent | 14.1 | 8.4-21.7 | |
| Moderate extent | 7.6 | 3.5-14.0 | |
| Small extent | 7.9 | 3.8-14.2 | |
| No extent | 11.9 | 6.7-19.2 | |
| No basis to judge/Not applicable | 32.1 | 23.7-40.5 | |
| No answer | 19.8 | 13.1-28.1 |
10m. Identifying and sharing effective program approaches with others
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 7.1 | 4.5-10.6 |
| Great extent | 25.8 | 21.2-30.4 | |
| Moderate extent | 20.3 | 16.2-24.4 | |
| Small extent | 11.0 | 8.0-14.7 | |
| No extent | 2.7 | 1.2-5.2 | |
| No basis to judge/Not applicable | 5.7 | 3.4-9.0 | |
| No answer | 27.3 | 22.5-32.1 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 6.5 | 2.7-12.8 |
| Great extent | 24.5 | 17.4-32.8 | |
| Moderate extent | 18.2 | 11.8-26.2 | |
| Small extent | 11.8 | 6.5-19.2 | |
| No extent | 2.9 | 0.8-7.4 | |
| No basis to judge/Not applicable | 6.1 | 2.5-12.0 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 3.3 | 0.9-8.6 |
| Great extent | 21.7 | 14.5-30.5 | |
| Moderate extent | 32.8 | 24.1-41.4 | |
| Small extent | 12.7 | 7.3-20.2 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 6.7 | 2.8-13.0 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 7.6 | 3.5-14.0 |
| Great extent | 27.4 | 19.4-35.5 | |
| Moderate extent | 23.9 | 16.5-32.6 | |
| Small extent | 14.4 | 8.7-22.0 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 3.6 | 1.1-8.4 | |
| No answer | 20.9 | 14.0-29.3 |
11. Please provide an example of how you use performance information.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
12. Over the past several years, for those program(s)/operation(s)/project(s) that you are involved
with, has managers' use of performance information at FDA increased, decreased or remained about the same?
Managers' use of performance information at FDA has ...
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Increased greatly | 16.4 | 12.5-21.0 |
| Increased somewhat | 27.3 | 22.7-31.9 | |
| Stayed about the same | 21.4 | 17.0-25.8 | |
| Decreased somewhat | 0.9 | 0.2-2.3 | |
| Decreased greatly | 0.2 | 0.0-0.6 | |
| No basis to judge | 6.7 | 4.4-9.8 | |
| No answer | 27.1 | 22.3-31.9 | |
| 2--CDER/CBER/CDRH Managers | Increased greatly | 13.1 | 7.6-20.6 |
| Increased somewhat | 25.9 | 18.5-34.5 | |
| Stayed about the same | 23.2 | 15.9-31.9 | |
| Decreased somewhat | 0.0 | 0.0-2.9 | |
| Decreased greatly | 0.0 | 0.0-2.9 | |
| No basis to judge | 7.7 | 3.8-13.5 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Increased greatly | 3.3 | 0.9-8.6 |
| Increased somewhat | 35.5 | 26.8-44.2 | |
| Stayed about the same | 28.4 | 20.1-36.7 | |
| Decreased somewhat | 1.7 | 0.2-6.1 | |
| Decreased greatly | 1.7 | 0.2-6.1 | |
| No basis to judge | 8.3 | 4.0-15.1 | |
| No answer | 21.1 | 14.0-29.7 | |
| 4--ORA Managers | Increased greatly | 22.0 | 15.0-30.5 |
| Increased somewhat | 28.8 | 20.7-37.0 | |
| Stayed about the same | 20.6 | 13.7-29.0 | |
| Decreased somewhat | 2.2 | 0.4-6.7 | |
| Decreased greatly | 0.0 | 0.0-3.1 | |
| No basis to judge | 6.5 | 2.8-12.6 | |
| No answer | 19.8 | 13.1-28.1 |
Performance Measurement (Continued)
13. Based on your experience with the program(s)/operation(s)/project(s) that you are involved with, to what extent, if at all, have the following factors hindered measuring performance or using the performance information?
13a. Difficulty determining meaningful measures
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 11.5 | 8.3-15.3 |
| Great extent | 18.3 | 14.3-22.2 | |
| Moderate extent | 22.2 | 17.7-26.6 | |
| Small extent | 11.9 | 8.6-15.9 | |
| No extent | 6.6 | 4.1-10.0 | |
| No basis to judge/Not applicable | 2.1 | 1.0-4.1 | |
| No answer | 27.5 | 22.6-32.3 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 10.5 | 5.7-17.2 |
| Great extent | 20.5 | 13.8-28.6 | |
| Moderate extent | 21.7 | 14.7-30.2 | |
| Small extent | 11.6 | 6.4-19.0 | |
| No extent | 3.6 | 1.1-8.6 | |
| No basis to judge/Not applicable | 2.1 | 0.3-6.8 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 16.1 | 9.9-24.1 |
| Great extent | 14.4 | 8.6-22.1 | |
| Moderate extent | 25.0 | 17.4-34.1 | |
| Small extent | 10.0 | 5.1-17.1 | |
| No extent | 8.3 | 4.0-15.1 | |
| No basis to judge/Not applicable | 5.0 | 1.8-10.9 | |
| No answer | 21.1 | 14.0-29.7 | |
| 4--ORA Managers | Very great extent | 10.7 | 5.9-17.4 |
| Great extent | 22.8 | 15.6-31.4 | |
| Moderate extent | 21.7 | 14.7-30.2 | |
| Small extent | 15.2 | 9.3-23.0 | |
| No extent | 6.5 | 2.8-12.6 | |
| No basis to judge/Not applicable | 2.2 | 0.4-6.7 | |
| No answer | 20.9 | 14.0-29.3 |
13b. Different parties are using different definitions to measure performance
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 8.9 | 6.1-12.4 |
| Great extent | 17.9 | 14.0-21.7 | |
| Moderate extent | 23.6 | 19.0-28.2 | |
| Small extent | 12.5 | 9.3-16.2 | |
| No extent | 7.1 | 4.5-10.5 | |
| No basis to judge/Not applicable | 3.0 | 1.5-5.3 | |
| No answer | 27.1 | 22.3-31.9 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 11.9 | 6.7-19.2 |
| Great extent | 18.5 | 11.9-26.7 | |
| Moderate extent | 24.9 | 17.5-33.5 | |
| Small extent | 8.6 | 4.6-14.6 | |
| No extent | 4.0 | 1.3-8.9 | |
| No basis to judge/Not applicable | 2.1 | 0.3-6.8 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 13.4 | 7.7-21.1 |
| Great extent | 22.1 | 15.0-30.7 | |
| Moderate extent | 16.7 | 10.3-24.9 | |
| Small extent | 13.4 | 7.7-21.1 | |
| No extent | 8.3 | 4.0-15.1 | |
| No basis to judge/Not applicable | 5.0 | 1.8-10.9 | |
| No answer | 21.1 | 14.0-29.7 | |
| 4--ORA Managers | Very great extent | 5.4 | 2.1-11.2 |
| Great extent | 20.2 | 13.4-28.4 | |
| Moderate extent | 23.9 | 16.5-32.6 | |
| Small extent | 19.8 | 13.1-28.1 | |
| No extent | 7.6 | 3.5-14.0 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.3 | |
| No answer | 19.8 | 13.1-28.1 |
13c. Difficulty obtaining valid or reliable data
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 7.0 | 4.5-10.2 |
| Great extent | 12.0 | 8.9-15.9 | |
| Moderate extent | 23.3 | 18.8-27.8 | |
| Small extent | 20.5 | 16.2-24.9 | |
| No extent | 7.3 | 4.9-10.4 | |
| No basis to judge/Not applicable | 2.9 | 1.4-5.2 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 6.0 | 2.5-11.7 |
| Great extent | 12.1 | 6.9-19.2 | |
| Moderate extent | 25.2 | 18.0-33.6 | |
| Small extent | 19.8 | 13.0-28.0 | |
| No extent | 4.8 | 1.7-10.3 | |
| No basis to judge/Not applicable | 2.1 | 0.3-6.8 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 11.7 | 6.4-19.1 |
| Great extent | 15.5 | 9.6-23.1 | |
| Moderate extent | 18.4 | 11.7-26.8 | |
| Small extent | 21.7 | 14.5-30.5 | |
| No extent | 10.0 | 5.1-17.1 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.6 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 5.7 | 2.4-11.4 |
| Great extent | 12.2 | 7.0-19.5 | |
| Moderate extent | 26.0 | 18.4-34.9 | |
| Small extent | 21.7 | 14.7-30.2 | |
| No extent | 10.9 | 5.9-17.9 | |
| No basis to judge/Not applicable | 3.6 | 1.1-8.4 | |
| No answer | 19.8 | 13.1-28.1 |
13d. Difficulty obtaining data in time to be useful
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 5.2 | 3.1-8.0 |
| Great extent | 10.9 | 8.1-14.2 | |
| Moderate extent | 21.0 | 16.7-25.4 | |
| Small extent | 20.7 | 16.4-25.0 | |
| No extent | 11.2 | 8.0-15.1 | |
| No basis to judge/Not applicable | 1.6 | 0.7-3.2 | |
| No answer | 29.4 | 24.6-34.3 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 6.3 | 2.8-12.0 |
| Great extent | 13.2 | 7.8-20.5 | |
| Moderate extent | 16.8 | 10.8-24.3 | |
| Small extent | 22.7 | 15.5-31.3 | |
| No extent | 6.9 | 3.1-13.1 | |
| No basis to judge/Not applicable | 0.9 | 0.1-4.4 | |
| No answer | 33.2 | 24.7-41.6 | |
| 3--CFSAN Managers | Very great extent | 8.3 | 4.0-15.1 |
| Great extent | 15.5 | 9.6-23.1 | |
| Moderate extent | 23.4 | 15.9-32.3 | |
| Small extent | 13.4 | 7.7-21.1 | |
| No extent | 16.7 | 10.3-24.9 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.6 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 3.3 | 0.9-8.3 |
| Great extent | 9.3 | 4.8-15.8 | |
| Moderate extent | 25.0 | 17.5-33.8 | |
| Small extent | 25.0 | 17.5-33.8 | |
| No extent | 13.0 | 7.5-20.5 | |
| No basis to judge/Not applicable | 2.5 | 0.6-6.8 | |
| No answer | 22.0 | 15.0-30.5 |
13e. Lack of incentives (e.g., rewards, positive recognition)
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 11.6 | 8.4-15.5 |
| Great extent | 12.7 | 9.3-16.7 | |
| Moderate extent | 20.9 | 16.7-25.1 | |
| Small extent | 15.4 | 11.8-19.7 | |
| No extent | 8.7 | 6.0-12.2 | |
| No basis to judge/Not applicable | 2.5 | 1.2-4.6 | |
| No answer | 28.1 | 23.3-33.0 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 14.7 | 8.9-22.4 |
| Great extent | 10.1 | 5.4-16.8 | |
| Moderate extent | 17.6 | 11.7-25.0 | |
| Small extent | 17.9 | 11.7-25.8 | |
| No extent | 5.4 | 2.2-11.1 | |
| No basis to judge/Not applicable | 1.2 | 0.1-5.7 | |
| No answer | 33.1 | 24.6-41.6 | |
| 3--CFSAN Managers | Very great extent | 18.4 | 11.7-26.8 |
| Great extent | 14.4 | 8.6-22.1 | |
| Moderate extent | 16.7 | 10.3-24.9 | |
| Small extent | 15.0 | 9.0-23.0 | |
| No extent | 9.4 | 4.8-16.1 | |
| No basis to judge/Not applicable | 6.7 | 2.8-13.0 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 5.7 | 2.4-11.4 |
| Great extent | 13.3 | 7.8-20.7 | |
| Moderate extent | 30.4 | 22.1-38.7 | |
| Small extent | 16.3 | 10.1-24.2 | |
| No extent | 11.9 | 6.7-19.2 | |
| No basis to judge/Not applicable | 2.5 | 0.6-6.8 | |
| No answer | 19.8 | 13.1-28.1 |
13f. Difficulty resolving conflicting interests of stakeholders, either internal or external
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 5.5 | 3.4-8.5 |
| Great extent | 9.3 | 6.5-12.9 | |
| Moderate extent | 15.9 | 12.3-19.5 | |
| Small extent | 21.1 | 16.8-25.4 | |
| No extent | 13.5 | 9.9-17.9 | |
| No basis to judge/Not applicable | 7.7 | 5.2-10.9 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 2.2 | 0.3-7.0 |
| Great extent | 11.3 | 6.3-18.3 | |
| Moderate extent | 13.8 | 8.2-21.2 | |
| Small extent | 21.3 | 14.5-29.5 | |
| No extent | 12.5 | 7.2-19.8 | |
| No basis to judge/Not applicable | 8.9 | 4.6-15.2 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 11.7 | 6.4-19.1 |
| Great extent | 10.0 | 5.1-17.1 | |
| Moderate extent | 20.5 | 13.6-28.8 | |
| Small extent | 20.0 | 13.1-28.6 | |
| No extent | 10.0 | 5.1-17.1 | |
| No basis to judge/Not applicable | 8.3 | 4.0-15.1 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 5.7 | 2.4-11.4 |
| Great extent | 9.8 | 5.1-16.6 | |
| Moderate extent | 20.9 | 14.0-29.3 | |
| Small extent | 22.8 | 15.6-31.4 | |
| No extent | 11.9 | 6.7-19.2 | |
| No basis to judge/Not applicable | 9.0 | 4.6-15.6 | |
| No answer | 19.8 | 13.1-28.1 |
13g. Difficulty distinguishing between the results produced by the program and results caused by other factors
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 5.5 | 3.5-8.2 |
| Great extent | 7.0 | 4.7-10.0 | |
| Moderate extent | 22.8 | 18.5-27.2 | |
| Small extent | 18.4 | 14.4-22.4 | |
| No extent | 13.6 | 10.0-17.9 | |
| No basis to judge/Not applicable | 5.7 | 3.5-8.7 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 5.3 | 2.1-10.6 |
| Great extent | 5.9 | 2.4-11.7 | |
| Moderate extent | 26.6 | 18.8-34.4 | |
| Small extent | 18.3 | 12.0-26.2 | |
| No extent | 7.8 | 3.7-14.2 | |
| No basis to judge/Not applicable | 6.1 | 2.5-12.0 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 11.7 | 6.4-19.1 |
| Great extent | 15.5 | 9.6-23.1 | |
| Moderate extent | 18.4 | 11.7-26.8 | |
| Small extent | 11.7 | 6.4-19.1 | |
| No extent | 15.0 | 9.0-23.0 | |
| No basis to judge/Not applicable | 8.3 | 4.0-15.1 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 5.7 | 2.4-11.4 |
| Great extent | 6.5 | 2.8-12.6 | |
| Moderate extent | 25.6 | 18.1-34.4 | |
| Small extent | 22.8 | 15.6-31.4 | |
| No extent | 15.2 | 9.3-23.0 | |
| No basis to judge/Not applicable | 4.3 | 1.5-9.8 | |
| No answer | 19.8 | 13.1-28.1 |
13h. Existing information technology and/or systems not capable of providing needed data
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 11.4 | 8.2-15.4 |
| Great extent | 12.0 | 8.7-16.0 | |
| Moderate extent | 19.8 | 15.6-23.9 | |
| Small extent | 16.1 | 12.4-20.3 | |
| No extent | 8.7 | 5.9-12.2 | |
| No basis to judge/Not applicable | 4.4 | 2.6-6.9 | |
| No answer | 27.7 | 22.9-32.5 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 10.0 | 5.4-16.6 |
| Great extent | 13.1 | 7.7-20.3 | |
| Moderate extent | 21.7 | 14.8-30.0 | |
| Small extent | 14.2 | 8.4-21.8 | |
| No extent | 5.9 | 2.5-11.6 | |
| No basis to judge/Not applicable | 4.1 | 1.3-9.5 | |
| No answer | 31.0 | 22.8-39.3 | |
| 3--CFSAN Managers | Very great extent | 11.1 | 6.0-18.2 |
| Great extent | 6.1 | 2.6-11.8 | |
| Moderate extent | 18.4 | 11.7-26.8 | |
| Small extent | 25.0 | 17.4-34.1 | |
| No extent | 11.7 | 6.4-19.1 | |
| No basis to judge/Not applicable | 8.3 | 4.0-15.1 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 12.6 | 7.3-19.7 |
| Great extent | 10.9 | 5.9-17.9 | |
| Moderate extent | 22.8 | 15.6-31.4 | |
| Small extent | 17.4 | 11.0-25.4 | |
| No extent | 9.8 | 5.1-16.6 | |
| No basis to judge/Not applicable | 5.7 | 2.4-11.4 | |
| No answer | 20.9 | 14.0-29.3 |
13i. Lack of staff who are knowledgeable about gathering and/or analyzing performance information
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 7.0 | 4.4-10.5 |
| Great extent | 9.8 | 7.1-13.2 | |
| Moderate extent | 18.2 | 14.3-22.1 | |
| Small extent | 18.8 | 14.6-22.9 | |
| No extent | 13.4 | 9.8-17.7 | |
| No basis to judge/Not applicable | 5.1 | 3.1-7.8 | |
| No answer | 27.7 | 22.9-32.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 5.4 | 2.0-11.3 |
| Great extent | 10.5 | 5.8-17.2 | |
| Moderate extent | 14.1 | 8.5-21.5 | |
| Small extent | 22.1 | 15.2-30.3 | |
| No extent | 11.6 | 6.5-18.8 | |
| No basis to judge/Not applicable | 5.1 | 1.9-10.7 | |
| No answer | 31.2 | 22.9-39.5 | |
| 3--CFSAN Managers | Very great extent | 9.4 | 4.8-16.1 |
| Great extent | 11.7 | 6.4-19.1 | |
| Moderate extent | 20.0 | 13.1-28.6 | |
| Small extent | 16.1 | 9.9-24.1 | |
| No extent | 16.7 | 10.3-24.9 | |
| No basis to judge/Not applicable | 6.7 | 2.8-13.0 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 6.5 | 2.8-12.6 |
| Great extent | 11.5 | 6.4-18.5 | |
| Moderate extent | 23.9 | 16.5-32.6 | |
| Small extent | 19.8 | 13.1-28.1 | |
| No extent | 10.9 | 5.9-17.9 | |
| No basis to judge/Not applicable | 6.5 | 2.8-12.6 | |
| No answer | 20.9 | 14.0-29.3 |
13j. Lack of ongoing top executive commitment or support for using performance information to make program/funding decisions
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 6.6 | 4.1-10.0 |
| Great extent | 8.3 | 5.8-11.4 | |
| Moderate extent | 14.0 | 10.6-18.0 | |
| Small extent | 16.0 | 12.3-19.6 | |
| No extent | 19.5 | 15.2-23.7 | |
| No basis to judge/Not applicable | 8.7 | 6.1-12.0 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 8.0 | 3.8-14.5 |
| Great extent | 6.3 | 2.6-12.5 | |
| Moderate extent | 16.8 | 10.7-24.6 | |
| Small extent | 14.3 | 8.7-21.8 | |
| No extent | 15.1 | 9.5-22.4 | |
| No basis to judge/Not applicable | 9.3 | 4.7-16.1 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 9.4 | 4.8-16.1 |
| Great extent | 10.0 | 5.1-17.1 | |
| Moderate extent | 13.4 | 7.7-21.1 | |
| Small extent | 19.4 | 12.6-27.9 | |
| No extent | 16.7 | 10.3-24.9 | |
| No basis to judge/Not applicable | 11.7 | 6.4-19.1 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 4.3 | 1.5-9.8 |
| Great extent | 14.4 | 8.7-22.0 | |
| Moderate extent | 15.2 | 9.3-23.0 | |
| Small extent | 19.8 | 13.1-28.1 | |
| No extent | 14.4 | 8.7-22.0 | |
| No basis to judge/Not applicable | 11.9 | 6.7-19.2 | |
| No answer | 19.8 | 13.1-28.1 |
13k. Lack of ongoing Congressional commitment or support for using performance information to make program/funding decisions
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 6.1 | 3.8-9.3 |
| Great extent | 9.6 | 6.9-12.9 | |
| Moderate extent | 10.2 | 7.3-13.8 | |
| Small extent | 10.9 | 7.7-14.8 | |
| No extent | 14.0 | 10.4-18.3 | |
| No basis to judge/Not applicable | 21.8 | 17.5-26.1 | |
| No answer | 27.4 | 22.6-32.2 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 6.0 | 2.5-12.0 |
| Great extent | 10.0 | 5.3-16.7 | |
| Moderate extent | 10.3 | 5.7-16.9 | |
| Small extent | 8.9 | 4.6-15.3 | |
| No extent | 12.0 | 6.9-19.1 | |
| No basis to judge/Not applicable | 21.5 | 14.5-29.9 | |
| No answer | 31.2 | 22.9-39.5 | |
| 3--CFSAN Managers | Very great extent | 6.7 | 2.8-13.0 |
| Great extent | 10.0 | 5.1-17.1 | |
| Moderate extent | 17.7 | 11.3-26.0 | |
| Small extent | 12.7 | 7.3-20.2 | |
| No extent | 10.0 | 5.1-17.1 | |
| No basis to judge/Not applicable | 23.4 | 15.9-32.3 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 7.6 | 3.5-14.0 |
| Great extent | 10.4 | 5.6-17.1 | |
| Moderate extent | 9.8 | 5.1-16.6 | |
| Small extent | 9.8 | 5.1-16.6 | |
| No extent | 14.1 | 8.4-21.7 | |
| No basis to judge/Not applicable | 28.5 | 20.4-36.6 | |
| No answer | 19.8 | 13.1-28.1 |
13l. Difficulty determining how to use performance information to improve the program
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 3.6 | 2.0-6.1 |
| Great extent | 10.2 | 7.2-13.9 | |
| Moderate extent | 18.9 | 14.9-22.9 | |
| Small extent | 24.3 | 19.8-28.8 | |
| No extent | 12.0 | 8.6-16.0 | |
| No basis to judge/Not applicable | 4.1 | 2.2-6.9 | |
| No answer | 26.9 | 22.2-31.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 3.2 | 0.8-8.3 |
| Great extent | 8.8 | 4.4-15.3 | |
| Moderate extent | 14.2 | 8.7-21.3 | |
| Small extent | 30.8 | 22.6-39.0 | |
| No extent | 8.7 | 4.3-15.4 | |
| No basis to judge/Not applicable | 4.3 | 1.4-9.9 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 3.3 | 0.9-8.6 |
| Great extent | 11.7 | 6.4-19.1 | |
| Moderate extent | 19.4 | 12.6-27.9 | |
| Small extent | 24.4 | 16.9-33.4 | |
| No extent | 15.0 | 9.0-23.0 | |
| No basis to judge/Not applicable | 6.7 | 2.8-13.0 | |
| No answer | 19.4 | 12.6-27.9 | |
| 4--ORA Managers | Very great extent | 6.5 | 2.8-12.6 |
| Great extent | 11.2 | 6.2-18.2 | |
| Moderate extent | 25.0 | 17.5-33.8 | |
| Small extent | 22.0 | 15.0-30.5 | |
| No extent | 12.2 | 7.0-19.5 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.3 | |
| No answer | 19.8 | 13.1-28.1 |
13m. Concern that OMB will micromanage programs in my agency
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 4.2 | 2.4-6.8 |
| Great extent | 6.5 | 4.2-9.5 | |
| Moderate extent | 14.3 | 10.7-18.6 | |
| Small extent | 12.1 | 8.8-15.9 | |
| No extent | 17.0 | 12.9-21.1 | |
| No basis to judge/Not applicable | 18.9 | 14.9-22.9 | |
| No answer | 27.1 | 22.3-31.9 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 2.2 | 0.3-7.0 |
| Great extent | 4.2 | 1.5-9.1 | |
| Moderate extent | 13.5 | 8.0-20.8 | |
| Small extent | 13.7 | 8.1-21.3 | |
| No extent | 17.1 | 10.9-24.9 | |
| No basis to judge/Not applicable | 19.3 | 12.7-27.5 | |
| No answer | 30.0 | 21.8-38.2 | |
| 3--CFSAN Managers | Very great extent | 6.7 | 2.8-13.0 |
| Great extent | 8.3 | 4.0-15.1 | |
| Moderate extent | 13.8 | 8.3-21.1 | |
| Small extent | 13.4 | 7.7-21.1 | |
| No extent | 13.4 | 7.7-21.1 | |
| No basis to judge/Not applicable | 23.4 | 15.9-32.3 | |
| No answer | 21.1 | 14.0-29.7 | |
| 4--ORA Managers | Very great extent | 4.3 | 1.5-9.8 |
| Great extent | 7.9 | 3.8-14.2 | |
| Moderate extent | 16.3 | 10.1-24.2 | |
| Small extent | 11.9 | 6.7-19.2 | |
| No extent | 17.7 | 11.3-25.7 | |
| No basis to judge/Not applicable | 22.0 | 15.0-30.5 | |
| No answer | 19.8 | 13.1-28.1 |
13n. Other - Please specify below.
(Note: In accord with the instructions provided for responding to Question 8, please note that the
"No Answer" category for this question includes respondents who did not answer "Yes" on
Question 8.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 2.9 | 1.4-5.2 |
| Great extent | 1.7 | 0.5-4.1 | |
| Moderate extent | 0.7 | 0.2-1.8 | |
| Small extent | 0.0 | 0.0-1.0 | |
| No extent | 1.2 | 0.3-2.8 | |
| No basis to judge/Not applicable | 21.1 | 16.7-25.5 | |
| No answer | 72.5 | 67.7-77.3 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 2.2 | 0.3-7.0 |
| Great extent | 1.9 | 0.3-6.1 | |
| Moderate extent | 0.0 | 0.0-2.9 | |
| Small extent | 0.0 | 0.0-2.9 | |
| No extent | 2.1 | 0.3-6.8 | |
| No basis to judge/Not applicable | 18.5 | 12.0-26.7 | |
| No answer | 75.2 | 66.5-82.7 | |
| 3--CFSAN Managers | Very great extent | 3.3 | 0.9-8.6 |
| Great extent | 0.0 | 0.0-4.8 | |
| Moderate extent | 3.3 | 0.9-8.6 | |
| Small extent | 0.0 | 0.0-4.8 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 21.1 | 14.0-29.7 | |
| No answer | 68.9 | 60.4-77.4 | |
| 4--ORA Managers | Very great extent | 5.4 | 2.1-11.2 |
| Great extent | 1.1 | 0.1-5.0 | |
| Moderate extent | 1.1 | 0.1-5.0 | |
| Small extent | 0.0 | 0.0-3.1 | |
| No extent | 0.0 | 0.0-3.1 | |
| No basis to judge/Not applicable | 26.0 | 18.4-34.9 | |
| No answer | 66.4 | 57.9-74.9 |
If you answered "Other" above, please specify other factors that hindered measuring performance or using the performance information?
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
Agency Climate
14. To what extent, if at all, do you agree with the following statements?
14a. FDA managers/supervisors at my level have the decision making authority they need to help FDA accomplish its strategic goals.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 8.2 | 5.5-11.7 |
| Great extent | 33.2 | 28.2-38.3 | |
| Moderate extent | 30.9 | 25.9-35.9 | |
| Small extent | 19.2 | 15.0-23.4 | |
| No extent | 5.7 | 3.6-8.5 | |
| No basis to judge/Not applicable | 1.7 | 0.7-3.6 | |
| No answer | 1.1 | 0.3-2.8 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 6.7 | 2.9-12.8 |
| Great extent | 39.9 | 31.2-48.6 | |
| Moderate extent | 31.1 | 22.8-39.4 | |
| Small extent | 13.5 | 7.9-21.1 | |
| No extent | 5.9 | 2.5-11.5 | |
| No basis to judge/Not applicable | 1.9 | 0.3-6.1 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 6.7 | 2.8-13.0 |
| Great extent | 27.8 | 19.5-36.0 | |
| Moderate extent | 34.4 | 25.7-43.2 | |
| Small extent | 22.8 | 15.4-31.6 | |
| No extent | 6.7 | 2.8-13.0 | |
| No basis to judge/Not applicable | 1.7 | 0.2-6.1 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 8.2 | 4.1-14.5 |
| Great extent | 27.4 | 19.4-35.5 | |
| Moderate extent | 26.4 | 18.7-35.2 | |
| Small extent | 25.0 | 17.5-33.8 | |
| No extent | 8.7 | 4.3-15.3 | |
| No basis to judge/Not applicable | 2.2 | 0.4-6.7 | |
| No answer | 2.2 | 0.4-6.7 |
14b. FDA managers/supervisors at my level are held accountable for the accomplishment of FDA's strategic goals.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 20.1 | 15.9-24.4 |
| Great extent | 40.9 | 35.7-46.1 | |
| Moderate extent | 24.5 | 19.8-29.2 | |
| Small extent | 10.0 | 7.0-13.8 | |
| No extent | 1.9 | 0.6-4.3 | |
| No basis to judge/Not applicable | 1.9 | 0.8-3.6 | |
| No answer | 0.7 | 0.1-2.3 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 14.5 | 8.8-22.0 |
| Great extent | 46.8 | 37.9-55.7 | |
| Moderate extent | 24.0 | 16.6-32.6 | |
| Small extent | 10.8 | 5.8-18.0 | |
| No extent | 2.0 | 0.3-6.3 | |
| No basis to judge/Not applicable | 0.9 | 0.1-4.4 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 6.7 | 2.8-13.0 |
| Great extent | 46.1 | 37.0-55.3 | |
| Moderate extent | 28.8 | 20.6-37.1 | |
| Small extent | 13.4 | 7.7-21.1 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.6 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 29.1 | 21.0-37.3 |
| Great extent | 38.3 | 29.6-47.0 | |
| Moderate extent | 18.5 | 11.9-26.6 | |
| Small extent | 8.7 | 4.3-15.3 | |
| No extent | 1.1 | 0.1-5.0 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.3 | |
| No answer | 1.1 | 0.1-5.0 |
14c. FDA managers/supervisors at my level are held accountable for the results of the program(s)/operation(s)/project(s) they are responsible for.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 30.3 | 25.4-35.2 |
| Great extent | 46.8 | 41.5-52.2 | |
| Moderate extent | 13.4 | 10.0-17.6 | |
| Small extent | 5.8 | 3.4-9.0 | |
| No extent | 1.4 | 0.5-3.1 | |
| No basis to judge/Not applicable | 1.1 | 0.4-2.5 | |
| No answer | 1.1 | 0.3-2.8 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 25.7 | 18.2-34.4 |
| Great extent | 49.9 | 41.1-58.7 | |
| Moderate extent | 15.0 | 9.1-22.7 | |
| Small extent | 6.5 | 2.7-12.8 | |
| No extent | 1.0 | 0.1-4.8 | |
| No basis to judge/Not applicable | 0.9 | 0.1-4.4 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 13.4 | 7.7-21.1 |
| Great extent | 52.8 | 43.6-62.0 | |
| Moderate extent | 22.1 | 15.0-30.7 | |
| Small extent | 6.7 | 2.8-13.0 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 1.7 | 0.2-6.1 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 43.6 | 34.7-52.4 |
| Great extent | 36.9 | 28.2-45.6 | |
| Moderate extent | 9.8 | 5.1-16.6 | |
| Small extent | 4.3 | 1.5-9.8 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 1.1 | 0.1-5.0 | |
| No answer | 2.2 | 0.4-6.7 |
14d. FDA managers/supervisors at my level use performance information to recognize employees for their performance.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 17.9 | 14.0-21.9 |
| Great extent | 37.6 | 32.4-42.8 | |
| Moderate extent | 29.6 | 24.7-34.4 | |
| Small extent | 9.5 | 6.6-13.2 | |
| No extent | 2.1 | 0.7-4.6 | |
| No basis to judge/Not applicable | 2.6 | 1.1-5.1 | |
| No answer | 0.7 | 0.1-2.3 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 12.2 | 6.9-19.5 |
| Great extent | 39.6 | 30.9-48.4 | |
| Moderate extent | 29.9 | 21.7-38.1 | |
| Small extent | 11.2 | 6.1-18.3 | |
| No extent | 2.9 | 0.8-7.6 | |
| No basis to judge/Not applicable | 3.1 | 0.8-8.2 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 13.4 | 7.7-21.1 |
| Great extent | 36.7 | 27.9-45.6 | |
| Moderate extent | 37.2 | 28.3-46.0 | |
| Small extent | 9.4 | 4.8-16.1 | |
| No extent | 0.0 | 0.0-4.8 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.6 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 28.5 | 20.4-36.6 |
| Great extent | 36.7 | 28.1-45.4 | |
| Moderate extent | 22.8 | 15.6-31.4 | |
| Small extent | 8.7 | 4.3-15.3 | |
| No extent | 1.1 | 0.1-5.0 | |
| No basis to judge/Not applicable | 1.1 | 0.1-5.0 | |
| No answer | 1.1 | 0.1-5.0 |
14e. Employees at FDA receive positive recognition for helping FDA accomplish its strategic goals.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 10.2 | 7.3-13.8 |
| Great extent | 28.6 | 23.6-33.6 | |
| Moderate extent | 32.2 | 27.2-37.2 | |
| Small extent | 23.9 | 19.3-28.5 | |
| No extent | 3.3 | 1.5-6.3 | |
| No basis to judge/Not applicable | 1.0 | 0.3-2.4 | |
| No answer | 0.7 | 0.1-2.3 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 6.4 | 2.7-12.6 |
| Great extent | 27.3 | 19.3-35.2 | |
| Moderate extent | 31.0 | 22.8-39.3 | |
| Small extent | 29.1 | 20.9-37.3 | |
| No extent | 4.2 | 1.4-9.6 | |
| No basis to judge/Not applicable | 0.9 | 0.1-4.4 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 13.4 | 7.7-21.1 |
| Great extent | 16.7 | 10.3-24.9 | |
| Moderate extent | 35.5 | 26.8-44.2 | |
| Small extent | 31.1 | 22.6-39.6 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 1.7 | 0.2-6.1 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 15.2 | 9.3-23.0 |
| Great extent | 32.4 | 24.0-40.8 | |
| Moderate extent | 31.8 | 23.4-40.2 | |
| Small extent | 17.4 | 11.0-25.4 | |
| No extent | 1.1 | 0.1-5.0 | |
| No basis to judge/Not applicable | 1.1 | 0.1-5.0 | |
| No answer | 1.1 | 0.1-5.0 |
14f. FDA is investing the resources needed to ensure that its performance data is of sufficient quality.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 3.4 | 1.8-5.9 |
| Great extent | 18.6 | 14.4-22.9 | |
| Moderate extent | 31.7 | 26.7-36.7 | |
| Small extent | 23.2 | 18.7-27.7 | |
| No extent | 5.6 | 3.3-8.8 | |
| No basis to judge/Not applicable | 16.6 | 12.7-20.5 | |
| No answer | 0.9 | 0.2-2.4 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 1.0 | 0.1-4.8 |
| Great extent | 18.5 | 12.2-26.4 | |
| Moderate extent | 31.0 | 22.7-39.3 | |
| Small extent | 23.1 | 15.8-31.8 | |
| No extent | 6.1 | 2.6-12.1 | |
| No basis to judge/Not applicable | 19.3 | 12.7-27.5 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 3.3 | 0.9-8.6 |
| Great extent | 8.3 | 4.0-15.1 | |
| Moderate extent | 31.7 | 23.2-40.3 | |
| Small extent | 28.2 | 20.2-36.2 | |
| No extent | 6.7 | 2.8-13.0 | |
| No basis to judge/Not applicable | 20.0 | 13.1-28.6 | |
| No answer | 1.7 | 0.2-6.1 | |
| 4--ORA Managers | Very great extent | 5.4 | 2.1-11.2 |
| Great extent | 22.8 | 15.6-31.4 | |
| Moderate extent | 25.9 | 18.4-34.6 | |
| Small extent | 23.9 | 16.5-32.6 | |
| No extent | 4.3 | 1.5-9.8 | |
| No basis to judge/Not applicable | 16.6 | 10.4-24.5 | |
| No answer | 1.1 | 0.1-5.0 |
14g. FDA's top leadership demonstrates a strong commitment to achieving results.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 23.4 | 19.1-27.8 |
| Great extent | 37.3 | 32.1-42.5 | |
| Moderate extent | 23.0 | 18.4-27.6 | |
| Small extent | 8.8 | 6.0-12.5 | |
| No extent | 1.0 | 0.3-2.4 | |
| No basis to judge/Not applicable | 6.0 | 3.7-9.2 | |
| No answer | 0.3 | 0.0-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 22.1 | 15.3-30.3 |
| Great extent | 38.2 | 29.6-46.7 | |
| Moderate extent | 21.3 | 14.3-29.8 | |
| Small extent | 13.4 | 7.8-20.9 | |
| No extent | 0.0 | 0.0-2.9 | |
| No basis to judge/Not applicable | 5.0 | 1.9-10.5 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 18.4 | 11.7-26.8 |
| Great extent | 38.2 | 29.4-47.0 | |
| Moderate extent | 23.4 | 15.9-32.3 | |
| Small extent | 6.7 | 2.8-13.0 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 10.0 | 5.1-17.1 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 29.9 | 21.7-38.1 |
| Great extent | 31.0 | 22.7-39.3 | |
| Moderate extent | 23.9 | 16.5-32.6 | |
| Small extent | 7.6 | 3.5-14.0 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 4.3 | 1.5-9.8 | |
| No answer | 1.1 | 0.1-5.0 |
14h. FDA's top leadership demonstrates a strong commitment to using performance information to guide decision making.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 10.8 | 7.7-14.6 |
| Great extent | 29.9 | 25.0-34.7 | |
| Moderate extent | 26.5 | 21.8-31.2 | |
| Small extent | 13.3 | 9.8-17.5 | |
| No extent | 3.2 | 1.7-5.3 | |
| No basis to judge/Not applicable | 15.5 | 11.7-19.9 | |
| No answer | 1.0 | 0.1-3.2 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 8.9 | 4.6-15.3 |
| Great extent | 27.8 | 20.3-35.4 | |
| Moderate extent | 27.5 | 19.9-35.2 | |
| Small extent | 18.5 | 12.0-26.7 | |
| No extent | 2.0 | 0.3-6.3 | |
| No basis to judge/Not applicable | 15.2 | 9.3-22.9 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 5.0 | 1.8-10.9 |
| Great extent | 19.4 | 12.6-27.9 | |
| Moderate extent | 34.4 | 25.7-43.2 | |
| Small extent | 12.7 | 7.3-20.2 | |
| No extent | 6.7 | 2.8-13.0 | |
| No basis to judge/Not applicable | 21.7 | 14.5-30.5 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 14.4 | 8.7-22.0 |
| Great extent | 35.7 | 27.1-44.2 | |
| Moderate extent | 21.7 | 14.7-30.2 | |
| Small extent | 8.7 | 4.3-15.3 | |
| No extent | 5.4 | 2.1-11.2 | |
| No basis to judge/Not applicable | 13.0 | 7.5-20.5 | |
| No answer | 1.1 | 0.1-5.0 |
14i. FDA is investing in resources to improve its capacity to use performance information.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 6.5 | 4.2-9.5 |
| Great extent | 20.8 | 16.4-25.2 | |
| Moderate extent | 29.7 | 24.9-34.5 | |
| Small extent | 15.1 | 11.3-19.6 | |
| No extent | 3.8 | 2.0-6.4 | |
| No basis to judge/Not applicable | 23.5 | 18.9-28.1 | |
| No answer | 0.7 | 0.1-2.2 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 5.0 | 1.9-10.2 |
| Great extent | 20.3 | 13.6-28.5 | |
| Moderate extent | 28.3 | 20.3-36.4 | |
| Small extent | 15.9 | 9.8-23.8 | |
| No extent | 2.0 | 0.3-6.3 | |
| No basis to judge/Not applicable | 28.5 | 20.4-36.6 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 3.3 | 0.9-8.6 |
| Great extent | 12.7 | 7.3-20.2 | |
| Moderate extent | 34.4 | 25.7-43.2 | |
| Small extent | 12.7 | 7.3-20.2 | |
| No extent | 6.7 | 2.8-13.0 | |
| No basis to judge/Not applicable | 30.1 | 21.6-38.5 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 9.8 | 5.1-16.6 |
| Great extent | 22.0 | 15.0-30.5 | |
| Moderate extent | 34.6 | 26.1-43.1 | |
| Small extent | 9.8 | 5.1-16.6 | |
| No extent | 5.4 | 2.1-11.2 | |
| No basis to judge/Not applicable | 16.3 | 10.1-24.2 | |
| No answer | 2.2 | 0.4-6.7 |
14j. FDA managers/supervisors at my level take steps to align program performance measures with agencywide goals and objectives.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 14.4 | 10.7-18.8 |
| Great extent | 39.8 | 34.8-44.8 | |
| Moderate extent | 27.9 | 23.1-32.8 | |
| Small extent | 9.2 | 6.3-12.7 | |
| No extent | 1.9 | 0.6-4.6 | |
| No basis to judge/Not applicable | 6.5 | 4.0-9.7 | |
| No answer | 0.3 | 0.0-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 14.5 | 8.8-22.0 |
| Great extent | 40.4 | 31.7-49.1 | |
| Moderate extent | 25.9 | 18.4-34.6 | |
| Small extent | 9.4 | 4.7-16.2 | |
| No extent | 1.0 | 0.1-4.8 | |
| No basis to judge/Not applicable | 8.8 | 4.6-15.1 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 5.0 | 1.8-10.9 |
| Great extent | 40.5 | 31.5-49.5 | |
| Moderate extent | 37.8 | 28.9-46.7 | |
| Small extent | 10.0 | 5.1-17.1 | |
| No extent | 0.0 | 0.0-4.8 | |
| No basis to judge/Not applicable | 6.7 | 2.8-13.0 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 16.3 | 10.1-24.2 |
| Great extent | 44.6 | 35.7-53.6 | |
| Moderate extent | 21.7 | 14.7-30.2 | |
| Small extent | 11.9 | 6.7-19.2 | |
| No extent | 1.1 | 0.1-5.0 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.3 | |
| No answer | 1.1 | 0.1-5.0 |
14k. FDA managers/supervisors at my level effectively communicate performance information on a routine basis.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 10.7 | 7.6-14.6 |
| Great extent | 35.1 | 30.1-40.1 | |
| Moderate extent | 34.6 | 29.4-39.7 | |
| Small extent | 14.8 | 11.2-19.1 | |
| No extent | 1.6 | 0.4-4.3 | |
| No basis to judge/Not applicable | 2.6 | 1.2-4.7 | |
| No answer | 0.6 | 0.1-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 6.0 | 2.6-11.7 |
| Great extent | 31.8 | 23.6-40.0 | |
| Moderate extent | 35.0 | 26.4-43.6 | |
| Small extent | 21.0 | 14.0-29.5 | |
| No extent | 1.0 | 0.1-4.8 | |
| No basis to judge/Not applicable | 4.9 | 1.9-10.2 | |
| No answer | 0.3 | 0.1-0.9 | |
| 3--CFSAN Managers | Very great extent | 3.3 | 0.9-8.6 |
| Great extent | 26.1 | 18.3-35.2 | |
| Moderate extent | 47.8 | 38.6-57.0 | |
| Small extent | 19.4 | 12.6-27.9 | |
| No extent | 0.0 | 0.0-4.8 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.6 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 17.7 | 11.3-25.7 |
| Great extent | 48.1 | 39.1-57.0 | |
| Moderate extent | 25.6 | 18.1-34.4 | |
| Small extent | 6.5 | 2.8-12.6 | |
| No extent | 0.0 | 0.0-3.1 | |
| No basis to judge/Not applicable | 1.1 | 0.1-5.0 | |
| No answer | 1.1 | 0.1-5.0 |
14l. FDA managers/supervisors at my level take steps to ensure that performance information is useful and/or appropriate.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 11.2 | 8.0-15.2 |
| Great extent | 35.4 | 30.3-40.4 | |
| Moderate extent | 33.0 | 27.9-38.1 | |
| Small extent | 12.1 | 8.8-16.1 | |
| No extent | 3.0 | 1.3-5.8 | |
| No basis to judge/Not applicable | 4.8 | 2.8-7.6 | |
| No answer | 0.5 | 0.1-1.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 7.7 | 3.6-14.2 |
| Great extent | 33.5 | 25.1-41.9 | |
| Moderate extent | 34.4 | 25.9-43.0 | |
| Small extent | 15.3 | 9.3-23.0 | |
| No extent | 1.0 | 0.1-4.8 | |
| No basis to judge/Not applicable | 8.1 | 3.9-14.4 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 1.7 | 0.2-6.1 |
| Great extent | 31.1 | 22.6-39.6 | |
| Moderate extent | 38.4 | 29.5-47.4 | |
| Small extent | 18.8 | 12.3-26.9 | |
| No extent | 0.0 | 0.0-4.8 | |
| No basis to judge/Not applicable | 8.3 | 4.0-15.1 | |
| No answer | 1.7 | 0.2-6.1 | |
| 4--ORA Managers | Very great extent | 16.6 | 10.4-24.5 |
| Great extent | 44.0 | 35.1-52.9 | |
| Moderate extent | 26.4 | 18.7-35.2 | |
| Small extent | 7.6 | 3.5-14.0 | |
| No extent | 4.3 | 1.5-9.8 | |
| No basis to judge/Not applicable | 0.0 | 0.0-3.1 | |
| No answer | 1.1 | 0.1-5.0 |
14m. FDA managers/supervisors at my level use performance information to share effective program approaches with others.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 7.8 | 5.2-11.2 |
| Great extent | 29.4 | 24.6-34.2 | |
| Moderate extent | 36.1 | 30.9-41.3 | |
| Small extent | 16.0 | 12.3-19.8 | |
| No extent | 3.2 | 1.5-5.9 | |
| No basis to judge/Not applicable | 7.1 | 4.5-10.6 | |
| No answer | 0.3 | 0.0-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 6.2 | 2.6-12.4 |
| Great extent | 23.5 | 16.4-31.8 | |
| Moderate extent | 37.1 | 28.6-45.7 | |
| Small extent | 21.1 | 14.1-29.6 | |
| No extent | 2.9 | 0.8-7.6 | |
| No basis to judge/Not applicable | 9.1 | 4.6-15.6 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 1.7 | 0.2-6.1 |
| Great extent | 24.4 | 16.9-33.4 | |
| Moderate extent | 38.4 | 29.5-47.4 | |
| Small extent | 25.5 | 17.9-34.4 | |
| No extent | 5.0 | 1.8-10.9 | |
| No basis to judge/Not applicable | 5.0 | 1.8-10.9 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 13.3 | 7.8-20.7 |
| Great extent | 36.1 | 27.5-44.8 | |
| Moderate extent | 32.9 | 24.4-41.3 | |
| Small extent | 11.2 | 6.2-18.2 | |
| No extent | 1.1 | 0.1-5.0 | |
| No basis to judge/Not applicable | 4.3 | 1.5-9.8 | |
| No answer | 1.1 | 0.1-5.0 |
Agency Climate (Continued)
The items listed in question 15 below focus on the program(s)/
operation(s)/project(s) that you are responsible for.
15. To what extent, if at all, do you agree with the following statements?
15a. The individual I report to periodically reviews with me the results or outcomes of the program(s)/operation(s)/project(s) that I am responsible for.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 20.3 | 16.0-24.6 |
| Great extent | 32.8 | 27.8-37.9 | |
| Moderate extent | 24.7 | 20.2-29.3 | |
| Small extent | 12.0 | 8.7-16.1 | |
| No extent | 7.6 | 5.0-11.1 | |
| No basis to judge/Not applicable | 2.0 | 0.7-4.5 | |
| No answer | 0.5 | 0.1-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 19.8 | 13.0-28.0 |
| Great extent | 34.9 | 26.4-43.4 | |
| Moderate extent | 21.0 | 14.1-29.4 | |
| Small extent | 15.3 | 9.3-23.0 | |
| No extent | 7.2 | 3.3-13.3 | |
| No basis to judge/Not applicable | 1.9 | 0.3-6.1 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 15.0 | 9.0-23.0 |
| Great extent | 31.7 | 23.2-40.3 | |
| Moderate extent | 29.4 | 21.1-37.8 | |
| Small extent | 12.1 | 7.0-19.1 | |
| No extent | 11.7 | 6.4-19.1 | |
| No basis to judge/Not applicable | 0.0 | 0.0-4.8 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 23.1 | 15.9-31.7 |
| Great extent | 25.6 | 18.1-34.4 | |
| Moderate extent | 32.9 | 24.4-41.3 | |
| Small extent | 9.8 | 5.1-16.6 | |
| No extent | 5.4 | 2.1-11.2 | |
| No basis to judge/Not applicable | 2.2 | 0.4-6.7 | |
| No answer | 1.1 | 0.1-5.0 |
15b. Funding decisions for the program(s)/
operation(s)/project(s) I am responsible for are based on
results or outcome-oriented performance information.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 6.7 | 4.4-9.9 |
| Great extent | 18.4 | 14.2-22.6 | |
| Moderate extent | 26.1 | 21.5-30.6 | |
| Small extent | 22.2 | 17.8-26.6 | |
| No extent | 12.5 | 9.1-16.6 | |
| No basis to judge/Not applicable | 13.7 | 10.2-17.9 | |
| No answer | 0.5 | 0.1-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 9.1 | 4.6-15.6 |
| Great extent | 14.7 | 9.1-22.0 | |
| Moderate extent | 26.2 | 18.7-34.9 | |
| Small extent | 25.3 | 17.8-34.2 | |
| No extent | 13.9 | 8.4-21.2 | |
| No basis to judge/Not applicable | 10.8 | 6.1-17.4 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 6.7 | 2.8-13.0 |
| Great extent | 16.7 | 10.3-24.9 | |
| Moderate extent | 30.5 | 22.1-38.9 | |
| Small extent | 22.8 | 15.4-31.6 | |
| No extent | 11.7 | 6.4-19.1 | |
| No basis to judge/Not applicable | 11.7 | 6.4-19.1 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 4.6 | 1.7-10.0 |
| Great extent | 17.7 | 11.3-25.7 | |
| Moderate extent | 24.2 | 16.8-32.9 | |
| Small extent | 22.0 | 15.0-30.5 | |
| No extent | 13.0 | 7.5-20.5 | |
| No basis to judge/Not applicable | 17.4 | 11.0-25.4 | |
| No answer | 1.1 | 0.1-5.0 |
15c. Staffing and personnel decisions for the program(s)/operation(s)/project(s) I am responsible for are based on results or outcome-oriented performance information.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 6.4 | 4.1-9.4 |
| Great extent | 21.8 | 17.3-26.2 | |
| Moderate extent | 29.9 | 25.2-34.7 | |
| Small extent | 22.8 | 18.4-27.2 | |
| No extent | 10.2 | 7.1-14.1 | |
| No basis to judge/Not applicable | 8.5 | 5.6-12.2 | |
| No answer | 0.5 | 0.1-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 7.0 | 3.2-13.1 |
| Great extent | 19.9 | 13.3-27.9 | |
| Moderate extent | 38.8 | 30.4-47.3 | |
| Small extent | 17.5 | 11.2-25.4 | |
| No extent | 9.8 | 5.1-16.7 | |
| No basis to judge/Not applicable | 7.0 | 3.2-12.8 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 8.3 | 4.0-15.1 |
| Great extent | 20.0 | 13.1-28.6 | |
| Moderate extent | 22.1 | 15.0-30.7 | |
| Small extent | 29.4 | 21.1-37.8 | |
| No extent | 13.4 | 7.7-21.1 | |
| No basis to judge/Not applicable | 6.7 | 2.8-13.0 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 5.4 | 2.1-11.2 |
| Great extent | 22.0 | 15.0-30.5 | |
| Moderate extent | 27.7 | 19.7-35.8 | |
| Small extent | 28.5 | 20.4-36.6 | |
| No extent | 8.7 | 4.3-15.3 | |
| No basis to judge/Not applicable | 6.5 | 2.8-12.6 | |
| No answer | 1.1 | 0.1-5.0 |
15d. Changes by management above my level to the program(s)/operation(s)/project(s) I am responsible for are based on results or outcome-oriented performance information.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 2.9 | 1.4-5.3 |
| Great extent | 21.8 | 17.3-26.3 | |
| Moderate extent | 29.1 | 24.4-33.9 | |
| Small extent | 21.2 | 16.8-25.5 | |
| No extent | 9.0 | 6.1-12.7 | |
| No basis to judge/Not applicable | 15.5 | 11.7-19.9 | |
| No answer | 0.5 | 0.1-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 2.9 | 0.8-7.4 |
| Great extent | 23.9 | 16.5-32.6 | |
| Moderate extent | 35.6 | 27.1-44.1 | |
| Small extent | 16.0 | 9.9-23.9 | |
| No extent | 9.6 | 5.0-16.4 | |
| No basis to judge/Not applicable | 12.0 | 6.9-19.1 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 5.0 | 1.8-10.9 |
| Great extent | 11.7 | 6.4-19.1 | |
| Moderate extent | 24.4 | 16.9-33.4 | |
| Small extent | 31.1 | 22.6-39.6 | |
| No extent | 12.7 | 7.3-20.2 | |
| No basis to judge/Not applicable | 15.0 | 9.0-23.0 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 1.1 | 0.1-5.0 |
| Great extent | 22.0 | 15.0-30.5 | |
| Moderate extent | 25.3 | 17.8-34.1 | |
| Small extent | 25.6 | 18.1-34.4 | |
| No extent | 6.5 | 2.8-12.6 | |
| No basis to judge/Not applicable | 18.5 | 11.9-26.6 | |
| No answer | 1.1 | 0.1-5.0 |
15e. It is easy to motivate employees to be more results-oriented in the
program(s)/
operation(s)/project(s) I am responsible for.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 5.5 | 3.4-8.4 |
| Great extent | 24.8 | 20.1-29.5 | |
| Moderate extent | 36.3 | 31.3-41.4 | |
| Small extent | 22.8 | 18.4-27.3 | |
| No extent | 6.2 | 3.8-9.5 | |
| No basis to judge/Not applicable | 3.8 | 2.0-6.6 | |
| No answer | 0.5 | 0.1-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 7.0 | 3.2-13.1 |
| Great extent | 21.3 | 14.5-29.4 | |
| Moderate extent | 39.8 | 31.1-48.5 | |
| Small extent | 21.8 | 14.8-30.2 | |
| No extent | 6.2 | 2.6-12.1 | |
| No basis to judge/Not applicable | 3.9 | 1.3-9.0 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 6.7 | 2.8-13.0 |
| Great extent | 17.7 | 11.3-26.0 | |
| Moderate extent | 36.7 | 27.9-45.6 | |
| Small extent | 29.4 | 21.1-37.8 | |
| No extent | 4.4 | 1.6-9.4 | |
| No basis to judge/Not applicable | 5.0 | 1.8-10.9 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 3.3 | 0.9-8.3 |
| Great extent | 24.8 | 17.4-33.5 | |
| Moderate extent | 38.0 | 29.3-46.7 | |
| Small extent | 23.9 | 16.5-32.6 | |
| No extent | 6.8 | 3.1-12.8 | |
| No basis to judge/Not applicable | 2.2 | 0.4-6.7 | |
| No answer | 1.1 | 0.1-5.0 |
15f. I have sufficient information on the validity of the performance data I use to make decisions.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 5.4 | 3.3-8.3 |
| Great extent | 28.8 | 24.1-33.5 | |
| Moderate extent | 32.3 | 27.2-37.4 | |
| Small extent | 19.4 | 15.3-23.6 | |
| No extent | 6.2 | 3.8-9.5 | |
| No basis to judge/Not applicable | 7.4 | 4.8-10.8 | |
| No answer | 0.5 | 0.1-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 5.2 | 2.0-10.8 |
| Great extent | 24.1 | 17.2-32.2 | |
| Moderate extent | 34.1 | 25.7-42.5 | |
| Small extent | 22.3 | 15.2-30.7 | |
| No extent | 6.1 | 2.6-12.1 | |
| No basis to judge/Not applicable | 8.1 | 4.0-14.5 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 5.0 | 1.8-10.9 |
| Great extent | 29.4 | 21.1-37.8 | |
| Moderate extent | 23.4 | 15.9-32.3 | |
| Small extent | 23.4 | 15.9-32.3 | |
| No extent | 5.4 | 2.5-10.1 | |
| No basis to judge/Not applicable | 13.4 | 7.7-21.1 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 5.7 | 2.4-11.4 |
| Great extent | 34.0 | 25.5-42.5 | |
| Moderate extent | 30.7 | 22.4-39.0 | |
| Small extent | 16.6 | 10.4-24.5 | |
| No extent | 6.5 | 2.8-12.6 | |
| No basis to judge/Not applicable | 5.4 | 2.1-11.2 | |
| No answer | 1.1 | 0.1-5.0 |
Agency Climate (Continued)
16. To what extent, if at all, do you believe that the following persons or entities pay attention to FDA's use of performance information in management decision making?
16a. Secretary of Health and Human Services
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 11.8 | 8.5-15.8 |
| Great extent | 13.5 | 10.0-17.6 | |
| Moderate extent | 19.4 | 15.1-23.7 | |
| Small extent | 13.7 | 10.3-17.7 | |
| No extent | 5.3 | 3.1-8.5 | |
| No basis to judge/Not applicable | 35.7 | 30.6-40.8 | |
| No answer | 0.6 | 0.1-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 7.0 | 3.2-13.1 |
| Great extent | 10.0 | 5.3-17.0 | |
| Moderate extent | 23.0 | 15.7-31.6 | |
| Small extent | 11.7 | 6.6-19.0 | |
| No extent | 3.2 | 1.0-7.8 | |
| No basis to judge/Not applicable | 44.7 | 35.9-53.5 | |
| No answer | 0.3 | 0.1-0.9 | |
| 3--CFSAN Managers | Very great extent | 10.0 | 5.1-17.1 |
| Great extent | 8.3 | 4.0-15.1 | |
| Moderate extent | 23.4 | 15.9-32.3 | |
| Small extent | 21.1 | 14.0-29.7 | |
| No extent | 5.0 | 1.8-10.9 | |
| No basis to judge/Not applicable | 32.2 | 23.6-40.7 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 16.3 | 10.1-24.2 |
| Great extent | 19.5 | 12.8-27.8 | |
| Moderate extent | 13.3 | 7.8-20.7 | |
| Small extent | 16.3 | 10.1-24.2 | |
| No extent | 5.4 | 2.1-11.2 | |
| No basis to judge/Not applicable | 28.1 | 20.0-36.1 | |
| No answer | 1.1 | 0.1-5.0 |
16b. FDA Commissioner
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 17.0 | 13.0-21.0 |
| Great extent | 23.4 | 18.9-27.9 | |
| Moderate extent | 17.0 | 13.0-21.6 | |
| Small extent | 7.8 | 5.3-11.1 | |
| No extent | 3.8 | 1.9-6.9 | |
| No basis to judge/Not applicable | 30.3 | 25.4-35.1 | |
| No answer | 0.7 | 0.1-2.2 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 11.2 | 6.2-18.2 |
| Great extent | 22.9 | 15.8-31.4 | |
| Moderate extent | 18.8 | 12.2-27.0 | |
| Small extent | 4.4 | 1.5-9.6 | |
| No extent | 2.9 | 0.8-7.6 | |
| No basis to judge/Not applicable | 39.8 | 31.1-48.6 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 15.0 | 9.0-23.0 |
| Great extent | 19.4 | 12.6-27.9 | |
| Moderate extent | 15.0 | 9.0-23.0 | |
| Small extent | 19.4 | 12.6-27.9 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 29.4 | 21.1-37.8 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 22.8 | 15.6-31.4 |
| Great extent | 27.4 | 19.4-35.5 | |
| Moderate extent | 15.2 | 9.3-23.0 | |
| Small extent | 6.5 | 2.8-12.6 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 23.7 | 16.5-32.3 | |
| No answer | 2.2 | 0.4-6.7 |
16c. Director of your Center or Office
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 26.2 | 21.6-30.9 |
| Great extent | 28.0 | 23.2-32.8 | |
| Moderate extent | 19.7 | 15.5-23.9 | |
| Small extent | 6.4 | 4.1-9.5 | |
| No extent | 4.8 | 2.6-7.9 | |
| No basis to judge/Not applicable | 13.5 | 10.0-17.6 | |
| No answer | 1.4 | 0.5-3.2 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 23.1 | 15.9-31.7 |
| Great extent | 26.8 | 19.0-34.6 | |
| Moderate extent | 25.7 | 18.1-34.5 | |
| Small extent | 5.6 | 2.1-11.6 | |
| No extent | 1.9 | 0.3-6.1 | |
| No basis to judge/Not applicable | 16.0 | 10.1-23.5 | |
| No answer | 0.9 | 0.1-4.4 | |
| 3--CFSAN Managers | Very great extent | 16.7 | 10.3-24.9 |
| Great extent | 30.1 | 21.6-38.5 | |
| Moderate extent | 24.4 | 16.9-33.4 | |
| Small extent | 13.4 | 7.7-21.1 | |
| No extent | 4.4 | 1.6-9.4 | |
| No basis to judge/Not applicable | 11.1 | 6.0-18.2 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 32.1 | 23.7-40.5 |
| Great extent | 26.4 | 18.7-35.2 | |
| Moderate extent | 15.2 | 9.3-23.0 | |
| Small extent | 6.5 | 2.8-12.6 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 13.3 | 7.8-20.7 | |
| No answer | 3.3 | 0.9-8.3 |
16d. The individual I report to
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 26.7 | 22.2-31.2 |
| Great extent | 31.9 | 26.9-36.9 | |
| Moderate extent | 22.6 | 18.3-27.0 | |
| Small extent | 9.7 | 6.7-13.5 | |
| No extent | 4.2 | 2.2-7.3 | |
| No basis to judge/Not applicable | 3.8 | 2.0-6.4 | |
| No answer | 1.0 | 0.3-2.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 19.6 | 13.0-27.8 |
| Great extent | 35.9 | 27.3-44.4 | |
| Moderate extent | 24.2 | 17.0-32.6 | |
| Small extent | 11.1 | 6.2-17.9 | |
| No extent | 5.3 | 2.0-11.2 | |
| No basis to judge/Not applicable | 3.9 | 1.3-9.0 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 20.0 | 13.1-28.6 |
| Great extent | 26.7 | 18.8-35.9 | |
| Moderate extent | 36.1 | 27.3-45.0 | |
| Small extent | 9.4 | 4.8-16.1 | |
| No extent | 2.7 | 0.8-6.7 | |
| No basis to judge/Not applicable | 5.0 | 1.8-10.9 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 38.6 | 29.9-47.3 |
| Great extent | 26.4 | 18.7-35.2 | |
| Moderate extent | 18.8 | 12.2-26.9 | |
| Small extent | 7.6 | 3.5-14.0 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.3 | |
| No answer | 3.3 | 0.9-8.3 |
16e. Managers and supervisors at my level
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 16.4 | 12.6-20.2 |
| Great extent | 37.6 | 32.5-42.7 | |
| Moderate extent | 26.3 | 21.6-31.0 | |
| Small extent | 10.9 | 7.8-14.8 | |
| No extent | 2.8 | 1.1-5.7 | |
| No basis to judge/Not applicable | 3.7 | 2.1-6.0 | |
| No answer | 2.3 | 0.8-5.0 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 10.7 | 5.7-17.7 |
| Great extent | 39.2 | 30.5-47.9 | |
| Moderate extent | 30.1 | 21.9-38.3 | |
| Small extent | 10.1 | 5.4-16.8 | |
| No extent | 3.1 | 0.8-8.2 | |
| No basis to judge/Not applicable | 5.8 | 2.5-11.3 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 10.0 | 5.1-17.1 |
| Great extent | 28.4 | 20.1-36.7 | |
| Moderate extent | 38.4 | 29.5-47.4 | |
| Small extent | 16.5 | 10.6-23.9 | |
| No extent | 0.0 | 0.0-4.8 | |
| No basis to judge/Not applicable | 6.7 | 2.8-13.0 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 28.8 | 20.7-37.0 |
| Great extent | 38.3 | 29.6-47.0 | |
| Moderate extent | 16.6 | 10.4-24.5 | |
| Small extent | 10.9 | 5.9-17.9 | |
| No extent | 1.1 | 0.1-5.0 | |
| No basis to judge/Not applicable | 2.2 | 0.4-6.7 | |
| No answer | 2.2 | 0.4-6.7 |
16f. Employees that report to me
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 11.2 | 8.0-15.1 |
| Great extent | 30.1 | 25.3-35.0 | |
| Moderate extent | 29.5 | 24.7-34.4 | |
| Small extent | 14.8 | 11.2-19.0 | |
| No extent | 6.9 | 4.4-10.3 | |
| No basis to judge/Not applicable | 6.7 | 4.2-10.1 | |
| No answer | 0.7 | 0.1-2.2 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 11.4 | 6.2-18.6 |
| Great extent | 33.4 | 25.0-41.8 | |
| Moderate extent | 23.9 | 16.7-32.5 | |
| Small extent | 15.9 | 9.8-23.8 | |
| No extent | 7.6 | 3.5-13.9 | |
| No basis to judge/Not applicable | 7.9 | 3.9-13.9 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 6.7 | 2.8-13.0 |
| Great extent | 21.1 | 14.0-29.7 | |
| Moderate extent | 38.4 | 29.5-47.4 | |
| Small extent | 19.4 | 12.6-27.9 | |
| No extent | 6.1 | 2.6-11.8 | |
| No basis to judge/Not applicable | 8.3 | 4.0-15.1 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 12.2 | 7.0-19.5 |
| Great extent | 33.6 | 25.1-42.2 | |
| Moderate extent | 24.8 | 17.4-33.5 | |
| Small extent | 17.4 | 11.0-25.4 | |
| No extent | 6.5 | 2.8-12.6 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.3 | |
| No answer | 2.2 | 0.4-6.7 |
16g. Office of Management and Budget (OMB)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 9.0 | 6.3-12.5 |
| Great extent | 12.6 | 9.3-16.7 | |
| Moderate extent | 14.5 | 10.9-18.8 | |
| Small extent | 9.8 | 6.7-13.6 | |
| No extent | 4.5 | 2.6-7.1 | |
| No basis to judge/Not applicable | 48.3 | 43.1-53.6 | |
| No answer | 1.1 | 0.3-3.0 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 4.4 | 1.6-9.3 |
| Great extent | 8.3 | 4.2-14.2 | |
| Moderate extent | 10.7 | 5.9-17.5 | |
| Small extent | 9.3 | 4.7-16.1 | |
| No extent | 6.9 | 3.0-13.1 | |
| No basis to judge/Not applicable | 59.3 | 50.6-68.0 | |
| No answer | 1.2 | 0.1-5.7 | |
| 3--CFSAN Managers | Very great extent | 16.7 | 10.3-24.9 |
| Great extent | 9.4 | 4.8-16.1 | |
| Moderate extent | 11.7 | 6.4-19.1 | |
| Small extent | 9.4 | 4.8-16.1 | |
| No extent | 8.3 | 4.0-15.1 | |
| No basis to judge/Not applicable | 44.5 | 35.3-53.6 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 10.9 | 5.9-17.9 |
| Great extent | 14.1 | 8.4-21.7 | |
| Moderate extent | 16.6 | 10.4-24.5 | |
| Small extent | 7.6 | 3.5-14.0 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 45.4 | 36.5-54.4 | |
| No answer | 2.2 | 0.4-6.7 |
16h. Congressional committees
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 11.0 | 8.1-14.6 |
| Great extent | 14.7 | 11.1-18.9 | |
| Moderate extent | 12.2 | 8.9-16.2 | |
| Small extent | 14.0 | 10.4-18.3 | |
| No extent | 9.1 | 6.2-12.7 | |
| No basis to judge/Not applicable | 38.7 | 33.6-43.7 | |
| No answer | 0.3 | 0.0-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 5.6 | 2.3-11.2 |
| Great extent | 8.4 | 4.3-14.6 | |
| Moderate extent | 10.3 | 5.4-17.2 | |
| Small extent | 14.8 | 9.1-22.3 | |
| No extent | 13.5 | 8.0-20.9 | |
| No basis to judge/Not applicable | 47.3 | 38.7-55.9 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 13.4 | 7.7-21.1 |
| Great extent | 11.7 | 6.4-19.1 | |
| Moderate extent | 11.1 | 6.0-18.2 | |
| Small extent | 17.7 | 11.3-26.0 | |
| No extent | 6.7 | 2.8-13.0 | |
| No basis to judge/Not applicable | 39.5 | 30.5-48.5 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 19.5 | 12.8-27.8 |
| Great extent | 20.9 | 14.0-29.3 | |
| Moderate extent | 14.1 | 8.4-21.7 | |
| Small extent | 8.7 | 4.3-15.3 | |
| No extent | 6.5 | 2.8-12.6 | |
| No basis to judge/Not applicable | 29.1 | 21.0-37.3 | |
| No answer | 1.1 | 0.1-5.0 |
16i. The audit community (e.g., GAO, Inspectors General)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 12.6 | 9.3-16.4 |
| Great extent | 12.9 | 9.7-16.7 | |
| Moderate extent | 14.7 | 11.0-19.0 | |
| Small extent | 11.0 | 7.8-15.0 | |
| No extent | 4.7 | 2.7-7.6 | |
| No basis to judge/Not applicable | 42.7 | 37.6-47.8 | |
| No answer | 1.4 | 0.4-3.4 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 7.7 | 3.7-13.9 |
| Great extent | 7.3 | 3.6-13.0 | |
| Moderate extent | 11.5 | 6.4-18.6 | |
| Small extent | 13.4 | 7.9-20.8 | |
| No extent | 5.6 | 2.1-11.6 | |
| No basis to judge/Not applicable | 54.2 | 45.8-62.7 | |
| No answer | 0.3 | 0.1-0.9 | |
| 3--CFSAN Managers | Very great extent | 16.7 | 10.3-24.9 |
| Great extent | 13.4 | 7.7-21.1 | |
| Moderate extent | 17.7 | 11.3-26.0 | |
| Small extent | 12.7 | 7.3-20.2 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 36.1 | 27.3-45.0 | |
| No answer | 1.7 | 0.2-6.1 | |
| 4--ORA Managers | Very great extent | 18.5 | 11.9-26.6 |
| Great extent | 19.1 | 12.5-27.2 | |
| Moderate extent | 16.3 | 10.1-24.2 | |
| Small extent | 4.3 | 1.5-9.8 | |
| No extent | 7.6 | 3.5-14.0 | |
| No basis to judge/Not applicable | 33.2 | 24.7-41.6 | |
| No answer | 1.1 | 0.1-5.0 |
16j. The general public
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 6.4 | 4.0-9.7 |
| Great extent | 9.5 | 6.6-13.1 | |
| Moderate extent | 13.9 | 10.3-18.1 | |
| Small extent | 21.8 | 17.4-26.2 | |
| No extent | 14.6 | 11.0-18.9 | |
| No basis to judge/Not applicable | 32.8 | 27.8-37.9 | |
| No answer | 1.0 | 0.3-2.3 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 6.1 | 2.6-12.1 |
| Great extent | 8.6 | 4.2-15.1 | |
| Moderate extent | 10.4 | 5.8-17.1 | |
| Small extent | 24.1 | 16.8-32.9 | |
| No extent | 13.5 | 8.0-20.9 | |
| No basis to judge/Not applicable | 37.2 | 28.8-45.7 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 1.7 | 0.2-6.1 |
| Great extent | 8.3 | 4.0-15.1 | |
| Moderate extent | 15.0 | 9.0-23.0 | |
| Small extent | 31.7 | 23.2-40.3 | |
| No extent | 17.1 | 10.9-25.0 | |
| No basis to judge/Not applicable | 24.4 | 16.9-33.4 | |
| No answer | 1.7 | 0.2-6.1 | |
| 4--ORA Managers | Very great extent | 8.7 | 4.3-15.3 |
| Great extent | 10.1 | 5.4-16.9 | |
| Moderate extent | 14.1 | 8.4-21.7 | |
| Small extent | 19.5 | 12.8-27.8 | |
| No extent | 14.1 | 8.4-21.7 | |
| No basis to judge/Not applicable | 31.3 | 23.0-39.6 | |
| No answer | 2.2 | 0.4-6.7 |
Training
17. During the past 3 years, has FDA provided, arranged, or paid for training that would help you to accomplish the following tasks?
17a. Conduct strategic planning
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Yes | 41.2 | 36.0-46.4 |
| No | 46.8 | 41.5-52.1 | |
| Not sure | 11.4 | 8.2-15.3 | |
| Not checked | 0.7 | 0.1-2.2 | |
| 2--CDER/CBER/CDRH Managers | Yes | 49.7 | 40.7-58.6 |
| No | 37.1 | 28.5-45.7 | |
| Not sure | 13.3 | 7.7-20.7 | |
| Not checked | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Yes | 39.5 | 30.5-48.5 |
| No | 52.2 | 43.0-61.4 | |
| Not sure | 8.3 | 4.0-15.1 | |
| Not checked | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Yes | 28.5 | 20.4-36.6 |
| No | 57.4 | 48.5-66.3 | |
| Not sure | 11.9 | 6.7-19.2 | |
| Not checked | 2.2 | 0.4-6.7 |
17b. Set program performance goals
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Yes | 45.8 | 40.7-51.0 |
| No | 41.3 | 36.3-46.2 | |
| Not sure | 11.7 | 8.6-15.3 | |
| Not checked | 1.2 | 0.3-3.2 | |
| 2--CDER/CBER/CDRH Managers | Yes | 56.3 | 47.5-65.0 |
| No | 27.3 | 19.5-35.1 | |
| Not sure | 15.4 | 9.4-23.3 | |
| Not checked | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Yes | 52.8 | 43.6-62.0 |
| No | 33.8 | 25.2-42.5 | |
| Not sure | 13.4 | 7.7-21.1 | |
| Not checked | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Yes | 28.2 | 20.1-36.3 |
| No | 58.8 | 49.9-67.6 | |
| Not sure | 11.9 | 6.7-19.2 | |
| Not checked | 1.1 | 0.1-5.0 |
17c. Develop program performance measures
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Yes | 42.9 | 37.7-48.1 |
| No | 43.1 | 38.0-48.2 | |
| Not sure | 13.6 | 10.3-17.6 | |
| Not checked | 0.3 | 0.0-1.6 | |
| 2--CDER/CBER/CDRH Managers | Yes | 52.3 | 43.4-61.2 |
| No | 28.1 | 20.3-36.0 | |
| Not sure | 19.6 | 13.0-27.6 | |
| Not checked | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Yes | 53.4 | 44.3-62.5 |
| No | 34.9 | 26.3-43.5 | |
| Not sure | 11.7 | 6.4-19.1 | |
| Not checked | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Yes | 28.2 | 20.1-36.3 |
| No | 60.9 | 52.2-69.7 | |
| Not sure | 9.8 | 5.1-16.6 | |
| Not checked | 1.1 | 0.1-5.0 |
17d. Assess the quality of performance data
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Yes | 31.8 | 26.8-36.8 |
| No | 49.3 | 44.0-54.5 | |
| Not sure | 17.1 | 13.2-21.0 | |
| Not checked | 1.9 | 0.6-4.6 | |
| 2--CDER/CBER/CDRH Managers | Yes | 36.1 | 27.5-44.7 |
| No | 39.1 | 30.6-47.6 | |
| Not sure | 24.8 | 17.4-33.4 | |
| Not checked | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Yes | 33.4 | 24.7-42.1 |
| No | 53.2 | 44.1-62.4 | |
| Not sure | 13.4 | 7.7-21.1 | |
| Not checked | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Yes | 28.2 | 20.1-36.3 |
| No | 57.7 | 48.8-66.6 | |
| Not sure | 11.9 | 6.7-19.2 | |
| Not checked | 2.2 | 0.4-6.7 |
17e. Use program performance information to make decisions
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Yes | 33.6 | 28.5-38.8 |
| No | 49.8 | 44.5-55.1 | |
| Not sure | 15.3 | 11.8-19.4 | |
| Not checked | 1.2 | 0.4-2.8 | |
| 2--CDER/CBER/CDRH Managers | Yes | 36.7 | 28.2-45.3 |
| No | 41.0 | 32.4-49.6 | |
| Not sure | 22.2 | 15.2-30.7 | |
| Not checked | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Yes | 25.0 | 17.4-34.1 |
| No | 54.9 | 45.8-64.0 | |
| Not sure | 20.0 | 13.1-28.6 | |
| Not checked | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Yes | 31.5 | 23.1-39.8 |
| No | 55.5 | 46.6-64.4 | |
| Not sure | 9.8 | 5.1-16.6 | |
| Not checked | 3.3 | 0.9-8.3 |
17f. Link the performance of program(s)/
operation(s)/project(s) to the achievement of
FDA's strategic goals
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Yes | 35.7 | 30.5-40.9 |
| No | 44.7 | 39.4-49.9 | |
| Not sure | 18.8 | 14.7-22.9 | |
| Not checked | 0.8 | 0.2-2.2 | |
| 2--CDER/CBER/CDRH Managers | Yes | 41.7 | 33.0-50.4 |
| No | 34.7 | 26.4-43.0 | |
| Not sure | 23.3 | 16.1-31.8 | |
| Not checked | 0.3 | 0.1-0.9 | |
| 3--CFSAN Managers | Yes | 23.4 | 15.9-32.3 |
| No | 58.3 | 49.2-67.3 | |
| Not sure | 18.4 | 11.7-26.8 | |
| Not checked | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Yes | 28.5 | 20.4-36.6 |
| No | 51.9 | 43.0-60.9 | |
| Not sure | 17.4 | 11.0-25.4 | |
| Not checked | 2.2 | 0.4-6.7 |
Management Challenges
18. Based on your experience with the program(s)/operation(s)/project(s) that you are involved with,
to what extent, if at all, do you believe that FDA is making progress addressing each of the following
management challenges?
(Select one answer in each row.)
Cross-Cutting Issues
18a. Improving its information technology and information management
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 9.1 | 6.2-12.8 |
| Great extent | 29.9 | 24.9-34.8 | |
| Moderate extent | 35.5 | 30.4-40.6 | |
| Small extent | 19.5 | 15.4-23.7 | |
| No extent | 3.7 | 1.9-6.5 | |
| No basis to judge/Not applicable | 1.9 | 0.8-3.8 | |
| No answer | 0.3 | 0.0-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 11.1 | 6.0-18.1 |
| Great extent | 27.8 | 19.8-35.9 | |
| Moderate extent | 37.3 | 28.6-46.0 | |
| Small extent | 17.8 | 11.6-25.4 | |
| No extent | 4.1 | 1.3-9.4 | |
| No basis to judge/Not applicable | 1.9 | 0.3-6.1 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 5.0 | 1.8-10.9 |
| Great extent | 21.1 | 14.0-29.7 | |
| Moderate extent | 39.5 | 30.5-48.5 | |
| Small extent | 31.1 | 22.6-39.6 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 0.0 | 0.0-4.8 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 6.8 | 3.1-12.8 |
| Great extent | 28.5 | 20.4-36.6 | |
| Moderate extent | 38.3 | 29.6-47.0 | |
| Small extent | 18.5 | 11.9-26.6 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 3.6 | 1.1-8.4 | |
| No answer | 1.1 | 0.1-5.0 |
18b. Improving access to outside data from other federal agencies and non-governmental entities
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 4.2 | 2.3-7.0 |
| Great extent | 16.3 | 12.5-20.8 | |
| Moderate extent | 34.0 | 29.0-39.1 | |
| Small extent | 21.1 | 16.8-25.4 | |
| No extent | 8.0 | 5.5-11.2 | |
| No basis to judge/Not applicable | 16.0 | 12.2-20.5 | |
| No answer | 0.3 | 0.0-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 5.4 | 2.2-11.1 |
| Great extent | 16.5 | 10.3-24.5 | |
| Moderate extent | 31.8 | 23.8-39.8 | |
| Small extent | 22.5 | 15.5-31.0 | |
| No extent | 7.1 | 3.2-13.2 | |
| No basis to judge/Not applicable | 16.7 | 10.8-24.0 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 0.0 | 0.0-4.8 |
| Great extent | 16.1 | 9.9-24.1 | |
| Moderate extent | 33.4 | 24.7-42.1 | |
| Small extent | 29.4 | 21.1-37.8 | |
| No extent | 11.1 | 6.0-18.2 | |
| No basis to judge/Not applicable | 10.0 | 5.1-17.1 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 3.6 | 1.1-8.4 |
| Great extent | 14.1 | 8.4-21.7 | |
| Moderate extent | 34.0 | 25.5-42.5 | |
| Small extent | 22.0 | 15.0-30.5 | |
| No extent | 9.8 | 5.1-16.6 | |
| No basis to judge/Not applicable | 15.5 | 9.5-23.3 | |
| No answer | 1.1 | 0.1-5.0 |
18c. Recruiting, retaining, and developing a workforce with knowledge, skills and abilities necessary to carry out its mission
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 12.0 | 8.7-16.0 |
| Great extent | 31.3 | 26.3-36.2 | |
| Moderate extent | 32.1 | 27.1-37.1 | |
| Small extent | 16.8 | 12.9-20.8 | |
| No extent | 5.0 | 2.7-8.2 | |
| No basis to judge/Not applicable | 2.2 | 1.0-4.1 | |
| No answer | 0.7 | 0.1-2.2 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 11.5 | 6.4-18.7 |
| Great extent | 33.5 | 25.1-41.9 | |
| Moderate extent | 29.7 | 21.5-37.9 | |
| Small extent | 17.3 | 11.3-24.9 | |
| No extent | 5.1 | 1.9-10.7 | |
| No basis to judge/Not applicable | 1.9 | 0.3-6.1 | |
| No answer | 0.9 | 0.1-4.4 | |
| 3--CFSAN Managers | Very great extent | 3.3 | 0.9-8.6 |
| Great extent | 21.7 | 14.5-30.5 | |
| Moderate extent | 48.2 | 39.1-57.4 | |
| Small extent | 20.0 | 13.1-28.6 | |
| No extent | 5.0 | 1.8-10.9 | |
| No basis to judge/Not applicable | 1.7 | 0.2-6.1 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 17.7 | 11.3-25.7 |
| Great extent | 26.7 | 19.0-35.5 | |
| Moderate extent | 31.5 | 23.1-39.8 | |
| Small extent | 17.4 | 11.0-25.4 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 3.6 | 1.1-8.4 | |
| No answer | 1.1 | 0.1-5.0 |
18d. Improving coordination and communication within FDA (both within and between Centers and Offices)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 6.1 | 3.8-9.2 |
| Great extent | 22.0 | 17.7-26.4 | |
| Moderate extent | 45.0 | 39.7-50.4 | |
| Small extent | 18.8 | 14.7-23.0 | |
| No extent | 4.3 | 2.2-7.4 | |
| No basis to judge/Not applicable | 3.4 | 1.8-5.8 | |
| No answer | 0.3 | 0.0-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 8.6 | 4.2-15.3 |
| Great extent | 23.2 | 16.0-31.7 | |
| Moderate extent | 44.7 | 35.9-53.6 | |
| Small extent | 16.7 | 10.6-24.5 | |
| No extent | 2.9 | 0.8-7.6 | |
| No basis to judge/Not applicable | 3.8 | 1.3-8.6 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 5.0 | 1.8-10.9 |
| Great extent | 13.4 | 7.7-21.1 | |
| Moderate extent | 50.5 | 41.3-59.7 | |
| Small extent | 28.4 | 20.1-36.7 | |
| No extent | 2.7 | 0.8-6.7 | |
| No basis to judge/Not applicable | 0.0 | 0.0-4.8 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 5.7 | 2.4-11.4 |
| Great extent | 19.5 | 12.8-27.8 | |
| Moderate extent | 50.5 | 41.6-59.5 | |
| Small extent | 15.5 | 9.5-23.3 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 4.3 | 1.5-9.8 | |
| No answer | 1.1 | 0.1-5.0 |
18e. Improving coordination and communication with other federal agencies
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 5.0 | 2.9-7.9 |
| Great extent | 13.6 | 10.2-17.6 | |
| Moderate extent | 41.6 | 36.4-46.8 | |
| Small extent | 17.3 | 13.3-21.4 | |
| No extent | 4.4 | 2.6-7.1 | |
| No basis to judge/Not applicable | 17.5 | 13.4-21.5 | |
| No answer | 0.5 | 0.1-1.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 6.4 | 2.7-12.5 |
| Great extent | 6.8 | 3.1-12.5 | |
| Moderate extent | 40.7 | 32.4-49.1 | |
| Small extent | 20.3 | 13.5-28.5 | |
| No extent | 4.9 | 1.9-10.2 | |
| No basis to judge/Not applicable | 21.0 | 14.6-28.6 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 3.3 | 0.9-8.6 |
| Great extent | 10.0 | 5.1-17.1 | |
| Moderate extent | 33.8 | 25.2-42.5 | |
| Small extent | 25.0 | 17.4-34.1 | |
| No extent | 12.7 | 7.3-20.2 | |
| No basis to judge/Not applicable | 13.4 | 7.7-21.1 | |
| No answer | 1.7 | 0.2-6.1 | |
| 4--ORA Managers | Very great extent | 5.4 | 2.1-11.2 |
| Great extent | 20.9 | 14.0-29.3 | |
| Moderate extent | 45.1 | 36.2-54.1 | |
| Small extent | 13.0 | 7.5-20.5 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 12.2 | 7.0-19.5 | |
| No answer | 1.1 | 0.1-5.0 |
18f. Improving coordination and communication with experts outside FDA (e.g., academia)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 5.0 | 2.9-7.9 |
| Great extent | 22.8 | 18.2-27.3 | |
| Moderate extent | 34.3 | 29.2-39.5 | |
| Small extent | 17.1 | 13.2-21.0 | |
| No extent | 3.1 | 1.7-5.2 | |
| No basis to judge/Not applicable | 17.1 | 13.1-21.1 | |
| No answer | 0.7 | 0.1-2.3 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 9.0 | 4.6-15.7 |
| Great extent | 26.9 | 19.0-34.8 | |
| Moderate extent | 36.3 | 27.7-45.0 | |
| Small extent | 13.9 | 8.5-21.1 | |
| No extent | 1.9 | 0.3-6.1 | |
| No basis to judge/Not applicable | 10.8 | 6.1-17.4 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 1.7 | 0.2-6.1 |
| Great extent | 13.4 | 7.7-21.1 | |
| Moderate extent | 40.5 | 31.5-49.5 | |
| Small extent | 26.7 | 18.8-35.9 | |
| No extent | 6.1 | 2.6-11.8 | |
| No basis to judge/Not applicable | 11.7 | 6.4-19.1 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 2.2 | 0.4-6.7 |
| Great extent | 17.7 | 11.3-25.7 | |
| Moderate extent | 28.5 | 20.4-36.6 | |
| Small extent | 19.8 | 13.1-28.1 | |
| No extent | 5.4 | 2.1-11.2 | |
| No basis to judge/Not applicable | 25.3 | 17.8-34.1 | |
| No answer | 1.1 | 0.1-5.0 |
18g. Improving the communication of product safety information to the public
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 13.6 | 10.0-17.9 |
| Great extent | 39.8 | 34.6-45.1 | |
| Moderate extent | 30.1 | 25.2-35.0 | |
| Small extent | 4.0 | 2.4-6.1 | |
| No extent | 1.6 | 0.7-3.2 | |
| No basis to judge/Not applicable | 10.1 | 7.0-14.0 | |
| No answer | 0.7 | 0.1-2.2 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 17.0 | 10.8-24.8 |
| Great extent | 38.5 | 29.8-47.3 | |
| Moderate extent | 34.7 | 26.1-43.3 | |
| Small extent | 1.9 | 0.3-6.1 | |
| No extent | 0.0 | 0.0-2.9 | |
| No basis to judge/Not applicable | 7.9 | 3.9-14.0 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 5.0 | 1.8-10.9 |
| Great extent | 36.7 | 27.9-45.6 | |
| Moderate extent | 35.5 | 26.8-44.2 | |
| Small extent | 13.4 | 7.7-21.1 | |
| No extent | 6.1 | 2.6-11.8 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.6 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 13.3 | 7.8-20.7 |
| Great extent | 37.2 | 28.5-45.9 | |
| Moderate extent | 26.7 | 19.0-35.5 | |
| Small extent | 5.4 | 2.1-11.2 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 11.9 | 6.7-19.2 | |
| No answer | 2.2 | 0.4-6.7 |
18h. Keeping pace with scientific advances necessary to regulate a diverse and expanding product base
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 4.9 | 2.7-8.2 |
| Great extent | 31.5 | 26.6-36.4 | |
| Moderate extent | 33.0 | 28.0-38.1 | |
| Small extent | 12.4 | 9.2-16.1 | |
| No extent | 1.7 | 0.6-3.7 | |
| No basis to judge/Not applicable | 15.7 | 12.0-20.1 | |
| No answer | 0.7 | 0.1-2.3 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 5.3 | 2.0-11.2 |
| Great extent | 37.7 | 29.1-46.3 | |
| Moderate extent | 32.2 | 23.8-40.6 | |
| Small extent | 10.4 | 5.6-17.3 | |
| No extent | 2.2 | 0.3-7.0 | |
| No basis to judge/Not applicable | 11.1 | 6.3-17.9 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 5.0 | 1.8-10.9 |
| Great extent | 25.0 | 17.4-34.1 | |
| Moderate extent | 41.1 | 32.1-50.2 | |
| Small extent | 18.8 | 12.3-26.9 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 8.3 | 4.0-15.1 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 2.2 | 0.4-6.7 |
| Great extent | 25.6 | 18.1-34.4 | |
| Moderate extent | 30.7 | 22.4-39.0 | |
| Small extent | 18.5 | 11.9-26.6 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 19.8 | 13.1-28.1 | |
| No answer | 1.1 | 0.1-5.0 |
18i. Addressing increased need for inspecting domestic establishments for all the product lines that FDA regulates
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 6.1 | 4.0-8.9 |
| Great extent | 24.3 | 19.8-28.9 | |
| Moderate extent | 30.5 | 25.6-35.4 | |
| Small extent | 15.7 | 12.1-19.9 | |
| No extent | 2.9 | 1.4-5.3 | |
| No basis to judge/Not applicable | 20.1 | 15.7-24.5 | |
| No answer | 0.3 | 0.0-1.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 3.0 | 0.8-7.7 |
| Great extent | 21.2 | 14.3-29.6 | |
| Moderate extent | 25.2 | 17.7-33.9 | |
| Small extent | 20.5 | 13.6-28.9 | |
| No extent | 4.4 | 1.4-10.1 | |
| No basis to judge/Not applicable | 25.8 | 18.3-34.4 | |
| No answer | 0.0 | 0.0-2.9 | |
| 3--CFSAN Managers | Very great extent | 3.3 | 0.9-8.6 |
| Great extent | 15.0 | 9.0-23.0 | |
| Moderate extent | 37.8 | 28.9-46.7 | |
| Small extent | 27.1 | 19.1-35.2 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 15.0 | 9.0-23.0 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 14.4 | 8.7-22.0 |
| Great extent | 33.2 | 24.7-41.6 | |
| Moderate extent | 26.0 | 18.4-34.9 | |
| Small extent | 10.9 | 5.9-17.9 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 11.2 | 6.2-18.2 | |
| No answer | 1.1 | 0.1-5.0 |
Overseeing Medical Product Safety
18j. Addressing increased need for inspecting foreign manufacturers
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 11.1 | 7.9-15.0 |
| Great extent | 23.7 | 19.3-28.2 | |
| Moderate extent | 23.6 | 19.0-28.2 | |
| Small extent | 7.8 | 5.3-11.1 | |
| No extent | 1.9 | 0.7-4.1 | |
| No basis to judge/Not applicable | 30.8 | 26.2-35.4 | |
| No answer | 1.1 | 0.3-2.5 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 8.4 | 4.1-14.9 |
| Great extent | 23.1 | 15.9-31.8 | |
| Moderate extent | 29.1 | 21.0-37.2 | |
| Small extent | 13.2 | 7.7-20.7 | |
| No extent | 4.1 | 1.3-9.5 | |
| No basis to judge/Not applicable | 21.0 | 14.5-28.8 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 1.7 | 0.2-6.1 |
| Great extent | 0.0 | 0.0-4.8 | |
| Moderate extent | 13.4 | 7.7-21.1 | |
| Small extent | 6.7 | 2.8-13.0 | |
| No extent | 0.0 | 0.0-4.8 | |
| No basis to judge/Not applicable | 75.0 | 65.9-82.6 | |
| No answer | 3.3 | 0.9-8.6 | |
| 4--ORA Managers | Very great extent | 18.8 | 12.2-26.9 |
| Great extent | 37.5 | 28.8-46.2 | |
| Moderate extent | 17.4 | 11.0-25.4 | |
| Small extent | 4.3 | 1.5-9.8 | |
| No extent | 1.1 | 0.1-5.0 | |
| No basis to judge/Not applicable | 19.8 | 13.1-28.1 | |
| No answer | 1.1 | 0.1-5.0 |
18k. Improving its inspection and monitoring of clinical trials
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 6.4 | 4.0-9.5 |
| Great extent | 19.5 | 15.1-23.8 | |
| Moderate extent | 19.3 | 15.2-23.5 | |
| Small extent | 9.6 | 6.7-13.2 | |
| No extent | 1.9 | 0.7-4.1 | |
| No basis to judge/Not applicable | 41.7 | 37.0-46.5 | |
| No answer | 1.6 | 0.6-3.2 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 7.2 | 3.3-13.3 |
| Great extent | 22.0 | 14.9-30.4 | |
| Moderate extent | 28.7 | 20.6-36.8 | |
| Small extent | 18.5 | 12.0-26.7 | |
| No extent | 3.2 | 0.8-8.3 | |
| No basis to judge/Not applicable | 19.4 | 13.1-27.1 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 0.0 | 0.0-4.8 |
| Great extent | 1.7 | 0.2-6.1 | |
| Moderate extent | 3.3 | 0.9-8.6 | |
| Small extent | 1.7 | 0.2-6.1 | |
| No extent | 0.0 | 0.0-4.8 | |
| No basis to judge/Not applicable | 88.3 | 80.9-93.6 | |
| No answer | 5.0 | 1.8-10.9 | |
| 4--ORA Managers | Very great extent | 9.8 | 5.1-16.6 |
| Great extent | 20.2 | 13.4-28.4 | |
| Moderate extent | 17.7 | 11.3-25.7 | |
| Small extent | 5.4 | 2.1-11.2 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 42.6 | 33.8-51.5 | |
| No answer | 2.2 | 0.4-6.7 |
18l. Improving its monitoring of post-market study commitments for medical products
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 6.3 | 3.9-9.5 |
| Great extent | 20.1 | 15.7-24.6 | |
| Moderate extent | 23.2 | 18.8-27.6 | |
| Small extent | 8.1 | 5.3-11.8 | |
| No extent | 2.5 | 1.1-4.8 | |
| No basis to judge/Not applicable | 38.6 | 33.9-43.3 | |
| No answer | 1.2 | 0.5-2.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 12.3 | 7.0-19.5 |
| Great extent | 26.6 | 18.9-35.5 | |
| Moderate extent | 31.5 | 23.3-39.7 | |
| Small extent | 11.6 | 6.4-18.9 | |
| No extent | 3.4 | 0.9-8.8 | |
| No basis to judge/Not applicable | 13.7 | 8.1-21.2 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 0.0 | 0.0-4.8 |
| Great extent | 1.7 | 0.2-6.1 | |
| Moderate extent | 6.7 | 2.8-13.0 | |
| Small extent | 1.7 | 0.2-6.1 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 83.3 | 75.1-89.7 | |
| No answer | 5.0 | 1.8-10.9 | |
| 4--ORA Managers | Very great extent | 3.3 | 0.9-8.3 |
| Great extent | 17.7 | 11.3-25.7 | |
| Moderate extent | 24.2 | 16.8-32.9 | |
| Small extent | 5.4 | 2.1-11.2 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 45.1 | 36.2-54.1 | |
| No answer | 1.1 | 0.1-5.0 |
18m. Improving its monitoring and evaluation of adverse events
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 7.2 | 4.6-10.6 |
| Great extent | 25.5 | 20.8-30.2 | |
| Moderate extent | 24.7 | 20.1-29.4 | |
| Small extent | 5.8 | 3.6-8.8 | |
| No extent | 1.5 | 0.5-3.5 | |
| No basis to judge/Not applicable | 33.8 | 29.2-38.4 | |
| No answer | 1.5 | 0.5-3.2 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 13.6 | 8.1-20.9 |
| Great extent | 32.6 | 24.2-41.1 | |
| Moderate extent | 29.9 | 21.8-38.0 | |
| Small extent | 9.6 | 4.9-16.4 | |
| No extent | 1.2 | 0.1-5.7 | |
| No basis to judge/Not applicable | 11.1 | 6.1-18.2 | |
| No answer | 2.0 | 0.3-6.3 | |
| 3--CFSAN Managers | Very great extent | 0.0 | 0.0-4.8 |
| Great extent | 8.3 | 4.0-15.1 | |
| Moderate extent | 10.0 | 5.1-17.1 | |
| Small extent | 3.3 | 0.9-8.6 | |
| No extent | 0.0 | 0.0-4.8 | |
| No basis to judge/Not applicable | 75.0 | 65.9-82.6 | |
| No answer | 3.3 | 0.9-8.6 | |
| 4--ORA Managers | Very great extent | 4.3 | 1.5-9.8 |
| Great extent | 23.1 | 15.9-31.7 | |
| Moderate extent | 25.3 | 17.8-34.1 | |
| Small extent | 4.3 | 1.5-9.8 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 38.6 | 29.9-47.3 | |
| No answer | 1.1 | 0.1-5.0 |
18n. Improving its review of promotional/
advertising materials for drugs
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 4.6 | 2.7-7.3 |
| Great extent | 16.6 | 12.7-21.1 | |
| Moderate extent | 18.3 | 14.3-22.2 | |
| Small extent | 5.2 | 3.0-8.2 | |
| No extent | 1.6 | 0.6-3.4 | |
| No basis to judge/Not applicable | 52.5 | 47.5-57.5 | |
| No answer | 1.2 | 0.5-2.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 9.2 | 4.8-15.6 |
| Great extent | 21.1 | 14.2-29.4 | |
| Moderate extent | 23.4 | 16.9-30.9 | |
| Small extent | 7.5 | 3.4-14.0 | |
| No extent | 1.0 | 0.1-4.8 | |
| No basis to judge/Not applicable | 36.9 | 28.7-45.0 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 0.0 | 0.0-4.8 |
| Great extent | 1.7 | 0.2-6.1 | |
| Moderate extent | 5.0 | 1.8-10.9 | |
| Small extent | 1.7 | 0.2-6.1 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 85.0 | 77.0-91.0 | |
| No answer | 5.0 | 1.8-10.9 | |
| 4--ORA Managers | Very great extent | 3.3 | 0.9-8.3 |
| Great extent | 15.5 | 9.5-23.3 | |
| Moderate extent | 16.6 | 10.4-24.5 | |
| Small extent | 5.4 | 2.1-11.2 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 54.9 | 46.0-63.8 | |
| No answer | 1.1 | 0.1-5.0 |
Overseeing Food Safety
18o. Performing its regulatory role under its current statutory authority
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 8.1 | 5.6-11.3 |
| Great extent | 21.1 | 17.0-25.3 | |
| Moderate extent | 20.0 | 16.1-24.0 | |
| Small extent | 6.5 | 4.2-9.5 | |
| No extent | 1.6 | 0.7-3.0 | |
| No basis to judge/Not applicable | 42.0 | 37.6-46.4 | |
| No answer | 0.7 | 0.1-2.3 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 2.0 | 0.3-6.3 |
| Great extent | 6.4 | 2.7-12.6 | |
| Moderate extent | 7.6 | 3.6-13.7 | |
| Small extent | 4.4 | 1.4-10.1 | |
| No extent | 1.0 | 0.1-4.8 | |
| No basis to judge/Not applicable | 77.6 | 69.0-84.7 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 11.7 | 6.4-19.1 |
| Great extent | 31.7 | 23.2-40.3 | |
| Moderate extent | 30.5 | 22.1-38.9 | |
| Small extent | 12.7 | 7.3-20.2 | |
| No extent | 8.3 | 4.0-15.1 | |
| No basis to judge/Not applicable | 5.0 | 1.8-10.9 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 15.5 | 9.5-23.3 |
| Great extent | 33.2 | 24.7-41.6 | |
| Moderate extent | 27.1 | 19.1-35.1 | |
| Small extent | 8.7 | 4.3-15.3 | |
| No extent | 1.1 | 0.1-5.0 | |
| No basis to judge/Not applicable | 13.3 | 7.8-20.7 | |
| No answer | 1.1 | 0.1-5.0 |
18p. Improving its monitoring of the safety of a globally sourced food supply
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 5.6 | 3.6-8.2 |
| Great extent | 19.3 | 15.3-23.3 | |
| Moderate extent | 17.7 | 14.1-21.4 | |
| Small extent | 10.1 | 7.2-13.6 | |
| No extent | 2.2 | 1.0-4.1 | |
| No basis to judge/Not applicable | 44.4 | 40.0-48.8 | |
| No answer | 0.7 | 0.1-2.3 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 2.2 | 0.3-7.0 |
| Great extent | 3.1 | 0.8-8.2 | |
| Moderate extent | 5.4 | 2.3-10.7 | |
| Small extent | 5.1 | 1.9-10.8 | |
| No extent | 2.2 | 0.3-7.0 | |
| No basis to judge/Not applicable | 80.9 | 72.8-87.6 | |
| No answer | 1.0 | 0.1-4.8 | |
| 3--CFSAN Managers | Very great extent | 8.3 | 4.0-15.1 |
| Great extent | 31.7 | 23.2-40.3 | |
| Moderate extent | 24.4 | 16.9-33.4 | |
| Small extent | 22.1 | 15.0-30.7 | |
| No extent | 6.7 | 2.8-13.0 | |
| No basis to judge/Not applicable | 6.7 | 2.8-13.0 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 12.2 | 7.0-19.5 |
| Great extent | 31.0 | 22.7-39.3 | |
| Moderate extent | 26.0 | 18.4-34.9 | |
| Small extent | 14.1 | 8.4-21.7 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 13.3 | 7.8-20.7 | |
| No answer | 1.1 | 0.1-5.0 |
Management Challenges - An Example
19. Please provide an example of how FDA has made progress or not made progress to address any of the management
challenges listed in question 18 above.
(In your answer, please indicate which challenge from question 18 your example applies to.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
Potential Improvements
20. To what extent, if at all, would each of the following improve your ability to contribute to FDA's goals and responsibilities?
20a. Additional staff with needed knowledge, skills, and abilities
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 41.1 | 35.8-46.4 |
| Great extent | 38.8 | 33.6-44.1 | |
| Moderate extent | 11.5 | 8.3-15.5 | |
| Small extent | 5.1 | 2.9-8.2 | |
| No extent | 1.5 | 0.4-3.7 | |
| No basis to judge/Not applicable | 1.2 | 0.4-2.8 | |
| No answer | 0.8 | 0.1-2.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 44.1 | 35.2-53.0 |
| Great extent | 33.4 | 24.9-41.9 | |
| Moderate extent | 12.6 | 7.2-20.0 | |
| Small extent | 7.7 | 3.6-14.1 | |
| No extent | 0.0 | 0.0-2.9 | |
| No basis to judge/Not applicable | 0.9 | 0.1-4.4 | |
| No answer | 1.2 | 0.1-5.7 | |
| 3--CFSAN Managers | Very great extent | 43.2 | 34.2-52.2 |
| Great extent | 43.4 | 34.3-52.5 | |
| Moderate extent | 8.3 | 4.0-15.1 | |
| Small extent | 3.3 | 0.9-8.6 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 0.0 | 0.0-4.8 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 36.7 | 28.1-45.4 |
| Great extent | 42.6 | 33.8-51.5 | |
| Moderate extent | 13.0 | 7.5-20.5 | |
| Small extent | 2.2 | 0.4-6.7 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 2.2 | 0.4-6.7 | |
| No answer | 1.1 | 0.1-5.0 |
20b. Additional staff developmental opportunities
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 24.8 | 20.2-29.5 |
| Great extent | 42.0 | 36.7-47.3 | |
| Moderate extent | 24.2 | 19.6-28.8 | |
| Small extent | 5.6 | 3.4-8.7 | |
| No extent | 0.6 | 0.2-1.7 | |
| No basis to judge/Not applicable | 2.0 | 0.8-4.0 | |
| No answer | 0.8 | 0.1-2.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 23.4 | 16.1-32.1 |
| Great extent | 38.1 | 29.6-46.7 | |
| Moderate extent | 28.8 | 20.9-36.8 | |
| Small extent | 5.2 | 2.0-10.8 | |
| No extent | 0.3 | 0.1-0.9 | |
| No basis to judge/Not applicable | 2.9 | 0.8-7.6 | |
| No answer | 1.2 | 0.1-5.7 | |
| 3--CFSAN Managers | Very great extent | 29.4 | 21.1-37.8 |
| Great extent | 32.8 | 24.1-41.4 | |
| Moderate extent | 21.1 | 14.0-29.7 | |
| Small extent | 15.0 | 9.0-23.0 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 0.0 | 0.0-4.8 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 28.1 | 20.0-36.1 |
| Great extent | 43.7 | 34.8-52.6 | |
| Moderate extent | 22.8 | 15.6-31.4 | |
| Small extent | 1.1 | 0.1-5.0 | |
| No extent | 1.1 | 0.1-5.0 | |
| No basis to judge/Not applicable | 2.2 | 0.4-6.7 | |
| No answer | 1.1 | 0.1-5.0 |
20c. Improved coordination and communication within FDA (both within and between Centers and Offices)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 35.0 | 29.9-40.2 |
| Great extent | 35.2 | 30.1-40.3 | |
| Moderate extent | 22.1 | 17.6-26.5 | |
| Small extent | 4.2 | 2.1-7.2 | |
| No extent | 0.8 | 0.1-2.6 | |
| No basis to judge/Not applicable | 1.9 | 0.8-3.9 | |
| No answer | 0.8 | 0.1-2.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 27.8 | 19.8-35.7 |
| Great extent | 35.4 | 26.9-43.9 | |
| Moderate extent | 27.3 | 19.4-35.1 | |
| Small extent | 5.2 | 2.0-11.1 | |
| No extent | 1.2 | 0.1-5.7 | |
| No basis to judge/Not applicable | 1.9 | 0.3-6.1 | |
| No answer | 1.2 | 0.1-5.7 | |
| 3--CFSAN Managers | Very great extent | 34.4 | 25.7-43.2 |
| Great extent | 43.8 | 34.7-53.0 | |
| Moderate extent | 21.7 | 14.5-30.5 | |
| Small extent | 0.0 | 0.0-4.8 | |
| No extent | 0.0 | 0.0-4.8 | |
| No basis to judge/Not applicable | 0.0 | 0.0-4.8 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 42.9 | 34.1-51.8 |
| Great extent | 34.0 | 25.5-42.5 | |
| Moderate extent | 14.4 | 8.7-22.0 | |
| Small extent | 3.3 | 0.9-8.3 | |
| No extent | 1.1 | 0.1-5.0 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.3 | |
| No answer | 1.1 | 0.1-5.0 |
20d. Improved coordination and communication with other federal governmental entities
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 21.8 | 17.3-26.2 |
| Great extent | 27.0 | 22.3-31.8 | |
| Moderate extent | 29.7 | 24.8-34.6 | |
| Small extent | 13.3 | 9.7-17.7 | |
| No extent | 2.4 | 0.9-5.0 | |
| No basis to judge/Not applicable | 4.9 | 3.0-7.6 | |
| No answer | 0.8 | 0.1-2.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 20.0 | 13.2-28.3 |
| Great extent | 21.2 | 14.2-29.7 | |
| Moderate extent | 30.1 | 22.3-37.9 | |
| Small extent | 17.3 | 11.0-25.4 | |
| No extent | 3.4 | 0.9-8.8 | |
| No basis to judge/Not applicable | 6.9 | 3.2-12.7 | |
| No answer | 1.2 | 0.1-5.7 | |
| 3--CFSAN Managers | Very great extent | 22.8 | 15.4-31.6 |
| Great extent | 42.8 | 33.7-51.9 | |
| Moderate extent | 27.8 | 19.5-36.0 | |
| Small extent | 1.7 | 0.2-6.1 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.6 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 23.9 | 16.5-32.6 |
| Great extent | 29.1 | 21.0-37.3 | |
| Moderate extent | 27.1 | 19.1-35.1 | |
| Small extent | 11.9 | 6.7-19.2 | |
| No extent | 1.1 | 0.1-5.0 | |
| No basis to judge/Not applicable | 5.7 | 2.4-11.4 | |
| No answer | 1.1 | 0.1-5.0 |
20e. Improved coordination and communication with state governmental entities
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 13.4 | 10.0-17.5 |
| Great extent | 24.8 | 20.3-29.2 | |
| Moderate extent | 23.3 | 18.8-27.9 | |
| Small extent | 17.6 | 13.3-21.8 | |
| No extent | 10.0 | 6.8-14.1 | |
| No basis to judge/Not applicable | 9.7 | 6.9-13.1 | |
| No answer | 1.2 | 0.3-3.1 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 5.6 | 2.1-11.6 |
| Great extent | 17.8 | 11.4-25.9 | |
| Moderate extent | 25.6 | 18.2-34.2 | |
| Small extent | 18.1 | 11.7-26.0 | |
| No extent | 13.6 | 8.0-21.3 | |
| No basis to judge/Not applicable | 17.2 | 11.0-25.0 | |
| No answer | 2.2 | 0.3-7.0 | |
| 3--CFSAN Managers | Very great extent | 21.7 | 14.5-30.5 |
| Great extent | 32.8 | 24.1-41.4 | |
| Moderate extent | 17.1 | 10.9-25.0 | |
| Small extent | 13.4 | 7.7-21.1 | |
| No extent | 8.3 | 4.0-15.1 | |
| No basis to judge/Not applicable | 6.7 | 2.8-13.0 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 19.8 | 13.1-28.1 |
| Great extent | 31.8 | 23.4-40.2 | |
| Moderate extent | 25.3 | 17.8-34.1 | |
| Small extent | 11.9 | 6.7-19.2 | |
| No extent | 3.3 | 0.9-8.3 | |
| No basis to judge/Not applicable | 6.8 | 3.1-12.8 | |
| No answer | 1.1 | 0.1-5.0 |
20f. Improved coordination and communication with foreign regulatory bodies
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 16.2 | 12.4-20.6 |
| Great extent | 28.1 | 23.7-32.6 | |
| Moderate extent | 22.5 | 17.9-27.0 | |
| Small extent | 16.4 | 12.5-20.9 | |
| No extent | 6.4 | 3.9-9.9 | |
| No basis to judge/Not applicable | 9.6 | 6.5-13.4 | |
| No answer | 0.8 | 0.1-2.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 12.4 | 7.1-19.7 |
| Great extent | 34.8 | 26.6-43.0 | |
| Moderate extent | 21.6 | 14.6-30.0 | |
| Small extent | 20.5 | 13.7-28.8 | |
| No extent | 3.4 | 1.0-8.4 | |
| No basis to judge/Not applicable | 6.1 | 2.6-12.1 | |
| No answer | 1.2 | 0.1-5.7 | |
| 3--CFSAN Managers | Very great extent | 21.7 | 14.5-30.5 |
| Great extent | 39.5 | 30.5-48.5 | |
| Moderate extent | 22.1 | 15.0-30.7 | |
| Small extent | 8.3 | 4.0-15.1 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 5.0 | 1.8-10.9 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 18.8 | 12.2-26.9 |
| Great extent | 22.3 | 15.2-30.8 | |
| Moderate extent | 24.2 | 16.8-32.9 | |
| Small extent | 15.2 | 9.3-23.0 | |
| No extent | 5.4 | 2.1-11.2 | |
| No basis to judge/Not applicable | 13.0 | 7.5-20.5 | |
| No answer | 1.1 | 0.1-5.0 |
20g. Improved coordination and communication with experts outside FDA (e.g., academia)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 16.8 | 12.8-20.9 |
| Great extent | 34.3 | 29.2-39.4 | |
| Moderate extent | 22.2 | 17.7-26.6 | |
| Small extent | 12.8 | 9.4-17.0 | |
| No extent | 4.8 | 2.6-8.0 | |
| No basis to judge/Not applicable | 8.3 | 5.6-11.9 | |
| No answer | 0.8 | 0.1-2.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 20.4 | 13.6-28.8 |
| Great extent | 33.7 | 25.3-42.1 | |
| Moderate extent | 23.7 | 16.5-32.2 | |
| Small extent | 13.6 | 8.1-21.0 | |
| No extent | 2.4 | 0.5-6.9 | |
| No basis to judge/Not applicable | 4.9 | 1.9-10.3 | |
| No answer | 1.2 | 0.1-5.7 | |
| 3--CFSAN Managers | Very great extent | 21.1 | 14.0-29.7 |
| Great extent | 39.5 | 30.5-48.5 | |
| Moderate extent | 22.8 | 15.4-31.6 | |
| Small extent | 10.0 | 5.1-17.1 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.6 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 13.0 | 7.5-20.5 |
| Great extent | 35.3 | 26.8-43.9 | |
| Moderate extent | 20.6 | 13.7-29.0 | |
| Small extent | 11.9 | 6.7-19.2 | |
| No extent | 5.4 | 2.1-11.2 | |
| No basis to judge/Not applicable | 12.6 | 7.3-19.7 | |
| No answer | 1.1 | 0.1-5.0 |
20h. Updated technologies or other tools for data sharing or information management
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 42.0 | 36.7-47.3 |
| Great extent | 36.5 | 31.3-41.7 | |
| Moderate extent | 13.7 | 10.2-17.8 | |
| Small extent | 3.7 | 1.9-6.4 | |
| No extent | 1.1 | 0.3-2.9 | |
| No basis to judge/Not applicable | 1.9 | 0.8-3.8 | |
| No answer | 1.2 | 0.3-3.1 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 43.7 | 34.8-52.6 |
| Great extent | 31.7 | 23.5-39.9 | |
| Moderate extent | 14.1 | 8.6-21.3 | |
| Small extent | 6.5 | 2.7-12.8 | |
| No extent | 0.9 | 0.1-4.4 | |
| No basis to judge/Not applicable | 0.9 | 0.1-4.4 | |
| No answer | 2.2 | 0.3-7.0 | |
| 3--CFSAN Managers | Very great extent | 41.1 | 32.1-50.2 |
| Great extent | 37.2 | 28.3-46.0 | |
| Moderate extent | 18.4 | 11.7-26.8 | |
| Small extent | 3.3 | 0.9-8.6 | |
| No extent | 0.0 | 0.0-4.8 | |
| No basis to judge/Not applicable | 0.0 | 0.0-4.8 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 46.2 | 37.3-55.2 |
| Great extent | 35.3 | 26.8-43.9 | |
| Moderate extent | 10.9 | 5.9-17.9 | |
| Small extent | 1.1 | 0.1-5.0 | |
| No extent | 1.1 | 0.1-5.0 | |
| No basis to judge/Not applicable | 4.3 | 1.5-9.8 | |
| No answer | 1.1 | 0.1-5.0 |
20i. Updated scientific technologies or other tools for the regulation of a diverse and expanding product base
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 35.0 | 30.0-40.1 |
| Great extent | 31.5 | 26.5-36.4 | |
| Moderate extent | 16.2 | 12.4-20.8 | |
| Small extent | 2.3 | 1.1-4.2 | |
| No extent | 1.7 | 0.5-4.1 | |
| No basis to judge/Not applicable | 12.1 | 8.7-16.3 | |
| No answer | 1.2 | 0.3-3.1 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 37.4 | 28.7-46.0 |
| Great extent | 29.0 | 20.9-37.1 | |
| Moderate extent | 21.3 | 14.3-29.8 | |
| Small extent | 2.0 | 0.3-6.3 | |
| No extent | 0.0 | 0.0-2.9 | |
| No basis to judge/Not applicable | 8.1 | 4.0-14.5 | |
| No answer | 2.2 | 0.3-7.0 | |
| 3--CFSAN Managers | Very great extent | 34.4 | 25.7-43.2 |
| Great extent | 38.8 | 29.9-47.8 | |
| Moderate extent | 18.4 | 11.7-26.8 | |
| Small extent | 3.3 | 0.9-8.6 | |
| No extent | 0.0 | 0.0-4.8 | |
| No basis to judge/Not applicable | 5.0 | 1.8-10.9 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 40.2 | 31.4-49.0 |
| Great extent | 33.8 | 25.4-42.2 | |
| Moderate extent | 8.7 | 4.3-15.3 | |
| Small extent | 3.3 | 0.9-8.3 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 10.9 | 5.9-17.9 | |
| No answer | 1.1 | 0.1-5.0 |
20j. Updated FDA guidance for industry
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 22.1 | 17.7-26.5 |
| Great extent | 32.0 | 27.1-36.9 | |
| Moderate extent | 23.9 | 19.6-28.2 | |
| Small extent | 7.0 | 4.6-10.0 | |
| No extent | 1.3 | 0.3-3.5 | |
| No basis to judge/Not applicable | 12.9 | 9.6-17.0 | |
| No answer | 0.8 | 0.1-2.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 28.4 | 20.5-36.3 |
| Great extent | 30.7 | 22.6-38.7 | |
| Moderate extent | 26.5 | 19.2-33.8 | |
| Small extent | 9.1 | 4.7-15.7 | |
| No extent | 0.0 | 0.0-2.9 | |
| No basis to judge/Not applicable | 4.1 | 1.3-9.5 | |
| No answer | 1.2 | 0.1-5.7 | |
| 3--CFSAN Managers | Very great extent | 20.0 | 13.1-28.6 |
| Great extent | 39.5 | 30.5-48.5 | |
| Moderate extent | 28.8 | 20.6-37.1 | |
| Small extent | 6.7 | 2.8-13.0 | |
| No extent | 1.7 | 0.2-6.1 | |
| No basis to judge/Not applicable | 3.3 | 0.9-8.6 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 15.2 | 9.3-23.0 |
| Great extent | 36.4 | 27.8-45.1 | |
| Moderate extent | 24.2 | 16.8-32.9 | |
| Small extent | 8.7 | 4.3-15.3 | |
| No extent | 0.0 | 0.0-3.1 | |
| No basis to judge/Not applicable | 14.4 | 8.7-22.0 | |
| No answer | 1.1 | 0.1-5.0 |
20k. Updated product safety regulations
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 22.5 | 18.1-26.9 |
| Great extent | 25.7 | 21.1-30.3 | |
| Moderate extent | 24.0 | 19.6-28.4 | |
| Small extent | 6.2 | 3.9-9.3 | |
| No extent | 2.2 | 0.9-4.4 | |
| No basis to judge/Not applicable | 17.8 | 13.6-22.0 | |
| No answer | 1.7 | 0.6-3.7 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 18.6 | 12.2-26.6 |
| Great extent | 24.3 | 17.0-32.9 | |
| Moderate extent | 30.2 | 22.0-38.4 | |
| Small extent | 11.0 | 6.1-17.8 | |
| No extent | 0.0 | 0.0-2.9 | |
| No basis to judge/Not applicable | 13.7 | 8.1-21.2 | |
| No answer | 2.2 | 0.3-7.0 | |
| 3--CFSAN Managers | Very great extent | 30.5 | 22.1-38.9 |
| Great extent | 25.0 | 17.4-34.1 | |
| Moderate extent | 27.8 | 19.5-36.0 | |
| Small extent | 6.7 | 2.8-13.0 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 6.7 | 2.8-13.0 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 26.0 | 18.4-34.9 |
| Great extent | 31.0 | 22.7-39.3 | |
| Moderate extent | 23.4 | 16.2-32.0 | |
| Small extent | 2.2 | 0.4-6.7 | |
| No extent | 2.2 | 0.4-6.7 | |
| No basis to judge/Not applicable | 13.0 | 7.5-20.5 | |
| No answer | 2.2 | 0.4-6.7 |
20l. Authority for increased access to private firm records during food related emergencies
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 26.8 | 22.7-31.0 |
| Great extent | 15.8 | 12.3-19.3 | |
| Moderate extent | 8.1 | 5.5-11.4 | |
| Small extent | 2.2 | 1.0-4.2 | |
| No extent | 3.3 | 1.5-6.1 | |
| No basis to judge/Not applicable | 43.1 | 38.5-47.7 | |
| No answer | 0.8 | 0.1-2.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 7.6 | 3.6-14.0 |
| Great extent | 6.5 | 2.9-12.4 | |
| Moderate extent | 5.2 | 2.0-10.9 | |
| Small extent | 3.0 | 0.8-7.7 | |
| No extent | 3.1 | 0.8-8.2 | |
| No basis to judge/Not applicable | 73.3 | 65.4-81.2 | |
| No answer | 1.2 | 0.1-5.7 | |
| 3--CFSAN Managers | Very great extent | 36.1 | 27.3-45.0 |
| Great extent | 31.1 | 22.6-39.6 | |
| Moderate extent | 12.7 | 7.3-20.2 | |
| Small extent | 3.3 | 0.9-8.6 | |
| No extent | 3.3 | 0.9-8.6 | |
| No basis to judge/Not applicable | 13.4 | 7.7-21.1 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 50.1 | 41.1-59.0 |
| Great extent | 26.0 | 18.4-34.9 | |
| Moderate extent | 9.8 | 5.1-16.6 | |
| Small extent | 2.2 | 0.4-6.7 | |
| No extent | 0.0 | 0.0-3.1 | |
| No basis to judge/Not applicable | 10.9 | 5.9-17.9 | |
| No answer | 1.1 | 0.1-5.0 |
20m. Authority to accredit third party food inspectors
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 9.4 | 6.7-12.7 |
| Great extent | 11.3 | 8.2-15.1 | |
| Moderate extent | 11.1 | 8.4-14.3 | |
| Small extent | 8.9 | 6.1-12.4 | |
| No extent | 7.7 | 5.1-11.1 | |
| No basis to judge/Not applicable | 50.8 | 46.1-55.6 | |
| No answer | 0.8 | 0.1-2.6 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 4.9 | 1.7-10.5 |
| Great extent | 5.1 | 1.9-10.8 | |
| Moderate extent | 3.2 | 1.0-7.8 | |
| Small extent | 3.0 | 0.8-7.7 | |
| No extent | 3.1 | 0.8-8.2 | |
| No basis to judge/Not applicable | 79.4 | 71.1-86.3 | |
| No answer | 1.2 | 0.1-5.7 | |
| 3--CFSAN Managers | Very great extent | 21.1 | 14.0-29.7 |
| Great extent | 13.4 | 7.7-21.1 | |
| Moderate extent | 17.1 | 10.9-25.0 | |
| Small extent | 10.0 | 5.1-17.1 | |
| No extent | 13.4 | 7.7-21.1 | |
| No basis to judge/Not applicable | 25.0 | 17.4-34.1 | |
| No answer | 0.0 | 0.0-4.8 | |
| 4--ORA Managers | Very great extent | 9.8 | 5.1-16.6 |
| Great extent | 16.9 | 10.7-24.8 | |
| Moderate extent | 22.8 | 15.6-31.4 | |
| Small extent | 15.5 | 9.5-23.3 | |
| No extent | 10.9 | 5.9-17.9 | |
| No basis to judge/Not applicable | 23.1 | 15.9-31.7 | |
| No answer | 1.1 | 0.1-5.0 |
20n. Other - Please specify below.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
| Question Choices |
Estimated Percentage |
95 Percent Confidence Interval |
|
|---|---|---|---|
| 1--All FDA Managers | Very great extent | 4.5 | 2.7-7.0 |
| Great extent | 1.7 | 0.7-3.4 | |
| Moderate extent | 1.1 | 0.3-2.8 | |
| Small extent | 0.0 | 0.0-1.0 | |
| No extent | 1.3 | 0.3-3.4 | |
| No basis to judge/Not applicable | 25.1 | 20.5-29.8 | |
| No answer | 66.3 | 61.3-71.3 | |
| 2--CDER/CBER/CDRH Managers | Very great extent | 2.1 | 0.3-6.8 |
| Great extent | 0.9 | 0.1-4.4 | |
| Moderate extent | 0.0 | 0.0-2.9 | |
| Small extent | 0.0 | 0.0-2.9 | |
| No extent | 3.4 | 0.9-8.8 | |
| No basis to judge/Not applicable | 29.4 | 21.3-37.4 | |
| No answer | 64.2 | 55.7-72.7 | |
| 3--CFSAN Managers | Very great extent | 6.7 | 2.8-13.0 |
| Great extent | 1.7 | 0.2-6.1 | |
| Moderate extent | 0.0 | 0.0-4.8 | |
| Small extent | 0.0 | 0.0-4.8 | |
| No extent | 0.0 | 0.0-4.8 | |
| No basis to judge/Not applicable | 17.7 | 11.3-26.0 | |
| No answer | 73.9 | 64.8-81.7 | |
| 4--ORA Managers | Very great extent | 7.9 | 3.8-14.2 |
| Great extent | 3.3 | 0.9-8.3 | |
| Moderate extent | 2.2 | 0.4-6.7 | |
| Small extent | 0.0 | 0.0-3.1 | |
| No extent | 0.0 | 0.0-3.1 | |
| No basis to judge/Not applicable | 26.0 | 18.4-34.9 | |
| No answer | 60.6 | 51.8-69.4 |
If you answered "Other" above, please specify other improvements.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
21. In your opinion, what are the top three issues that FDA's Management should address to achieve its goals
and responsibilities?
Issue #1:
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
Issue #2:
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
Issue #3:
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
Additional Comments and Submit Your Responses to GAO
22. If you have any comments that would expand on your responses to any questions in this survey,
please enter them in the space below.
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
Please continue to the survey completion question below.
23. Are you ready to submit your final completed survey to GAO?
(This is equivalent to mailing a completed paper survey to us. It
tells us that your answers are official and final.)
| The SAS System |
| Survey of Performance and Management at the Food and Drug Administration (FDA) |
| U.S. Government Accountability Office |
data intentionally not reported |
You may view and print your completed survey by clicking on the Summary link in
the menu to the left..